##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##SAMPLE=<ID=NA12878_03,Gender=female,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected>
##PIPELINE=megSAP 0.1-742-ged8ba02
#chr	start	end	ref	obs	NA12878_03	filter	quality	gene	variant_type	coding_and_splicing	RepeatMasker	dbSNP	1000g	gnomAD_sub	ESP_sub	gnomAD	phyloP	PolyPhen	Sift	OMIM	fathmm-MKL	CADD	REVEL	ClinVar	HGMD	COSMIC	NGSD_hom	NGSD_het	classification	classification_comment	validation	gene_info
chr1	27687466	27687466	G	T	het		QUAL=11836;DP=722;AF=0.51;MQM=60	MAP3K6	missense_variant	MAP3K6:NM_004672.4:missense_variant:MODERATE:exon14/29:c.1866C>A:p.Asn622Lys,MAP3K6:NM_001297609.1:missense_variant:MODERATE:exon13/28:c.1842C>A:p.Asn614Lys		rs35659744	0.122	0.000,0.021	0.000	0.2959	0.0290	T,T	T,T,T,T,.							COSM1559293, COSM1559292	67	266				DDX11L1 (inh=n/a pLI=n/a)
chr1	45797505	45797505	C	G	het		QUAL=3753;DP=228;AF=0.50;MQM=60	MUTYH,HPDL	missense_variant,downstream_gene_variant	MUTYH:NM_001128425.1:missense_variant:MODERATE:exon12/16:c.1014G>C:p.Gln338His,MUTYH:NM_001048174.1:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His,MUTYH:NM_001293191.1:missense_variant:MODERATE:exon12/16:c.963G>C:p.Gln321His,MUTYH:NM_001293195.1:missense_variant:MODERATE:exon13/17:c.930G>C:p.Gln310His,MUTYH:NM_001048172.1:missense_variant:MODERATE:exon12/16:c.933G>C:p.Gln311His,MUTYH:NM_001048173.1:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His,MUTYH:NM_001293196.1:missense_variant:MODERATE:exon12/16:c.654G>C:p.Gln218His,MUTYH:NM_001048171.1:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His,MUTYH:NM_001293190.1:missense_variant:MODERATE:exon12/16:c.975G>C:p.Gln325His,MUTYH:NM_001293192.1:missense_variant:MODERATE:exon12/16:c.654G>C:p.Gln218His,MUTYH:NM_012222.2:missense_variant:MODERATE:exon12/16:c.1005G>C:p.Gln335His,HPDL:NM_032756.2:downstream_gene_variant:MODIFIER::c.*1392C>G:		rs3219489	0.3135	0.000	0.021,0.000	0.2492	0.0510	T	T,T,T,T,T,T,T,T,T,T,T,T	604933 [MUTYH (provisional) Adenomas,multiple colorectal|Gastric cancer,somatic|Colorectal adenomatous polyposis,autosomal recessive,with pilomatricomas];				RCV000034684.1 [benign]; RCV000079500.5 [benign]; RCV000131427.2 [benign]; RCV000144634.1 [benign]; 	CM083726 [CLASS=DFP MUT=ALT PHEN="Reduced activity" GENE=MUTYH]; 	COSM3751252	97	568				WASH7P (inh=n/a pLI=n/a)
chr1	62713224	62713224	C	G	hom		QUAL=1166;DP=37;AF=1.00;MQM=60	KANK4	missense_variant	KANK4:NM_181712.4:missense_variant:MODERATE:exon9/10:c.2803G>C:p.Val935Leu		rs2941679	0.9862	0.974	0.974	0.9598	0.6980	T	T,T,T,T								946	87				AL627309.1 (inh=n/a pLI=n/a)
chr1	62713246	62713246	G	A	het		QUAL=1649;DP=117;AF=0.44;MQM=60	KANK4	synonymous_variant	KANK4:NM_181712.4:synonymous_variant:LOW:exon9/10:c.2781C>T:p.His927His		rs10889315	0.3189	0.389	0.389	0.4209										COSM426544	189	491				AL627309.1 (inh=n/a pLI=n/a)
chr1	62728784	62728784	A	G	hom		QUAL=38124;DP=1194;AF=1.00;MQM=60	KANK4	missense_variant	KANK4:NM_181712.4:missense_variant:MODERATE:exon7/10:c.2519T>C:p.Val840Ala		rs2666472	0.7159	0.74	0.74	0.7338	2.8390	T	T,T,T							COSM4144131	545	403				AL627309.1 (inh=n/a pLI=n/a), PRPF31 (inh=AD pLI=0.97), 34P13.14 (inh=n/a pLI=n/a)
chr1	62728838	62728838	T	C	hom		QUAL=35243;DP=1128;AF=1.00;MQM=60	KANK4	missense_variant	KANK4:NM_181712.4:missense_variant:MODERATE:exon7/10:c.2465A>G:p.His822Arg		rs2258470	0.7163	0.741	0.741	0.734	3.3070	T	T,T,T								545	404				AL627309.1 (inh=n/a pLI=n/a), PRPF31 (inh=AD pLI=0.97), 34P13.14 (inh=n/a pLI=n/a)
chr1	62728861	62728861	T	C	hom		QUAL=35547;DP=1118;AF=1.00;MQM=60	KANK4	synonymous_variant	KANK4:NM_181712.4:synonymous_variant:LOW:exon7/10:c.2442A>G:p.Lys814Lys		rs2260581	0.7163	0.741	0.741	0.7338											545	405				PRPF31 (inh=AD pLI=0.97), 206L10.1 (inh=n/a pLI=n/a), 206L10.3 (inh=n/a pLI=n/a)
chr1	62728918	62728918	G	A	hom		QUAL=5510;DP=180;AF=1.00;MQM=60	KANK4	synonymous_variant	KANK4:NM_181712.4:synonymous_variant:LOW:exon7/10:c.2385C>T:p.Pro795Pro		rs2262110	0.7161	0.742	0.742	0.7338											547	404				PRPF31 (inh=AD pLI=0.97), 206L10.1 (inh=n/a pLI=n/a), 206L10.3 (inh=n/a pLI=n/a)
chr1	62732421	62732421	T	C	het		QUAL=13777;DP=857;AF=0.52;MQM=60	KANK4	missense_variant	KANK4:NM_181712.4:missense_variant:MODERATE:exon6/10:c.2302A>G:p.Thr768Ala		rs11207949	0.3055	0.284	0.284	0.2449	2.3800	T	T,T,T								50	368				LINC00115 (inh=n/a pLI=n/a)
chr1	62738904	62738904	T	C	hom		QUAL=1818;DP=62;AF=1.00;MQM=60	KANK4	synonymous_variant	KANK4:NM_181712.4:synonymous_variant:LOW:exon3/10:c.1872A>G:p.Pro624Pro		rs7516290	0.8005	0.738	0.738	0.6733											489	433				LINC00115 (inh=n/a pLI=n/a)
chr1	62739198	62739198	G	A	het		QUAL=2166;DP=140;AF=0.49;MQM=60	KANK4	synonymous_variant	KANK4:NM_181712.4:synonymous_variant:LOW:exon3/10:c.1578C>T:p.Ser526Ser		rs17855078	0.2506	0.308	0.308	0.3309											114	480				LINC00115 (inh=n/a pLI=n/a)
chr1	62740065	62740065	A	G	het		QUAL=1790;DP=119;AF=0.49;MQM=60	KANK4	synonymous_variant	KANK4:NM_181712.4:synonymous_variant:LOW:exon3/10:c.711T>C:p.Gly237Gly		rs12127930	0.4822	0.452	0.452	0.4271										COSM4144132	210	523				LINC00115 (inh=n/a pLI=n/a)
chr1	62740446	62740446	T	C	hom		QUAL=7265;DP=230;AF=1.00;MQM=60	KANK4	synonymous_variant	KANK4:NM_181712.4:synonymous_variant:LOW:exon3/10:c.330A>G:p.Pro110Pro		rs2666506	0.8045	0.745	0.745	0.6742											491	432				LINC00115 (inh=n/a pLI=n/a)
chr1	62740449	62740449	T	C	hom		QUAL=7265;DP=230;AF=1.00;MQM=60	KANK4	synonymous_variant	KANK4:NM_181712.4:synonymous_variant:LOW:exon3/10:c.327A>G:p.Ser109Ser		rs2666507	0.781	0.737	0.737	0.6734											489	433				SAMD11 (inh=n/a pLI=0.00), AL645608.1 (inh=n/a pLI=n/a)
chr1	120458004	120458004	A	T	het		QUAL=2123;DP=127;AF=0.55;MQM=60	NOTCH2	synonymous_variant	NOTCH2:NM_024408.3:synonymous_variant:LOW:exon34/34:c.7341T>A:p.Gly2447Gly		rs6685892	0.1925	0.129	0.129	0.1038				600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];							11	217				SAMD11 (inh=n/a pLI=0.00)
chr1	120539331	120539331	C	T	het	low_MQM	QUAL=30961;DP=1886;AF=0.52;MQM=49	NOTCH2	intron_variant	NOTCH2:NM_024408.3:intron_variant:MODIFIER:exon4/33:c.751+289G>A:,NOTCH2:NM_001200001.1:intron_variant:MODIFIER:exon4/21:c.751+289G>A:		rs2124109	0	0.44	0.44	0				600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];						COSM248829	0	867				SAMD11 (inh=n/a pLI=0.00)
chr1	120611496	120611496	C	A	het	low_MQM	QUAL=393;DP=41;AF=0.49;MQM=47	NOTCH2	intron_variant	NOTCH2:NM_024408.3:intron_variant:MODIFIER:exon1/33:c.73+452G>T:,NOTCH2:NM_001200001.1:intron_variant:MODIFIER:exon1/21:c.73+452G>T:		rs138685616	0	0.074	0.074	0				600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];							12	174				SAMD11 (inh=n/a pLI=0.00)
chr1	120611960	120611960	C	T	het	low_MQM	QUAL=9250;DP=1920;AF=0.21;MQM=47	NOTCH2	missense_variant	NOTCH2:NM_024408.3:missense_variant:MODERATE:exon1/34:c.61G>A:p.Ala21Thr,NOTCH2:NM_001200001.1:missense_variant:MODERATE:exon1/22:c.61G>A:p.Ala21Thr		rs2603926	0	0.259	0.259	0	0.4330	T	T	600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];						COSM1600651	0	643				SAMD11 (inh=n/a pLI=0.00)
chr1	120611964	120611964	G	C	het		QUAL=22127;DP=1927;AF=0.38;MQM=58	NOTCH2	missense_variant	NOTCH2:NM_024408.3:missense_variant:MODERATE:exon1/34:c.57C>G:p.Cys19Trp,NOTCH2:NM_001200001.1:missense_variant:MODERATE:exon1/22:c.57C>G:p.Cys19Trp		rs11810554	0	0.406	0.406	0	0.7660	T,T	.,T	600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];						COSM132738	5	1181				SAMD11 (inh=n/a pLI=0.00), NOC2L (inh=n/a pLI=0.00)
chr1	120612003	120612004	GG	-	het	low_MQM;anno_high_impact	QUAL=8237;DP=2016;AF=0.19;MQM=47	NOTCH2	frameshift_variant	NOTCH2:NM_024408.3:frameshift_variant:HIGH:exon1/34:c.17_18delCC:p.Pro6fs,NOTCH2:NM_001200001.1:frameshift_variant:HIGH:exon1/22:c.17_18delCC:p.Pro6fs		rs372504208	0	0.343	0.343	0				600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];						COSM132830	0	650	3	[3] old entry - no details available		SAMD11 (inh=n/a pLI=0.00), NOC2L (inh=n/a pLI=0.00)
chr1	120612006	120612006	G	A	het		QUAL=24336;DP=2004;AF=0.39;MQM=58	NOTCH2	synonymous_variant	NOTCH2:NM_024408.3:synonymous_variant:LOW:exon1/34:c.15C>T:p.Arg5Arg,NOTCH2:NM_001200001.1:synonymous_variant:LOW:exon1/22:c.15C>T:p.Arg5Arg		rs4021006	0.394	0.422	0.422	0	1.0740			600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];				RCV000173523.1 [uncertain significance]; 		COSM1320072	1	1178				NOC2L (inh=n/a pLI=0.00)
chr1	120612034	120612034	T	G	het	low_MQM	QUAL=8088;DP=1994;AF=0.20;MQM=47	NOTCH2	5_prime_UTR_variant	NOTCH2:NM_024408.3:5_prime_UTR_variant:MODIFIER:exon1/34:c.-14A>C:,NOTCH2:NM_001200001.1:5_prime_UTR_variant:MODIFIER:exon1/22:c.-14A>C:	(CGC)n	rs201668322	0	0.124	0.124	0											0	363				NOC2L (inh=n/a pLI=0.00)
chr2	17942775	17942775	T	A	hom		QUAL=3027;DP=91;AF=1.00;MQM=60	GEN1	missense_variant	GEN1:NM_001130009.1:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr,GEN1:NM_182625.3:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr		rs1812152	0.8137	0.714	0.714	0.6259	0.5670	T	T,T,T,T								403	499				NOC2L (inh=n/a pLI=0.00)
chr2	17954027	17954027	G	A	hom		QUAL=959;DP=29;AF=1.00;MQM=60	GEN1	missense_variant	GEN1:NM_001130009.1:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn,GEN1:NM_182625.3:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn		rs300175	0.977	0.993	0.993	0.9998	-2.1950	T	T,T,T								1035	1				NOC2L (inh=n/a pLI=0.00)
chr2	17962450	17962450	A	G	hom		QUAL=3047;DP=93;AF=1.00;MQM=60	GEN1	synonymous_variant	GEN1:NM_001130009.1:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657Glu,GEN1:NM_182625.3:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657Glu		rs300168	0.5739	0.576	0.576	0.5184											276	540				NOC2L (inh=n/a pLI=0.00)
chr2	17962518	17962518	C	T	hom		QUAL=3588;DP=111;AF=1.00;MQM=60	GEN1	missense_variant	GEN1:NM_001130009.1:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile,GEN1:NM_182625.3:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile		rs300169	0.758	0.698	0.698	0.6245	0.1800	T	T,T,T								404	494				NOC2L (inh=n/a pLI=0.00)
chr2	47601106	47601106	T	C	het		QUAL=843;DP=41;AF=0.73;MQM=60	EPCAM,MIR559	missense_variant,upstream_gene	EPCAM:NM_002354.2:missense_variant:MODERATE:exon3/9:c.344T>C:p.Met115Thr,MIR559:NR_030286.1:upstream_gene:MODIFIER::n.-1T>C:		rs1126497	0.6661	0.52	0.52	0.4328	0.0400	T	T,T,T	185535 [EPCAM (confirmed) Diarrhea 5,with tufting enteropathy,congenital|Colorectal cancer,hereditary nonpolyposis,type 8];				RCV000162369.1 [benign]; 	CM1110060 [CLASS=DP MUT=REF PHEN="Breast cancer increased risk association with" GENE=EPCAM]; 	COSM3927762	273	685				NOC2L (inh=n/a pLI=0.00)
chr2	48010488	48010488	G	A	het	low_DP;pred_pathogenic_1	QUAL=178;DP=14;AF=0.50;MQM=60	MSH6	missense_variant,5_prime_UTR_variant,upstream_gene	MSH6:NM_000179.2:missense_variant:MODERATE:exon1/10:c.116G>A:p.Gly39Glu,MSH6:NM_001281492.1:missense_variant:MODERATE:exon1/8:c.116G>A:p.Gly39Glu,MSH6:NM_001281493.1:5_prime_UTR_variant:MODIFIER:exon1/9:c.-621G>A:,MSH6:NM_001281494.1:upstream_gene:MODIFIER::c.-794G>A:		rs1042821	0.2009	0.178	0.178	0.1724	1.7010	T	T,D,T	600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5|Endometrial cancer,familial|Mismatch repair cancer syndrome];				RCV000030258.3 [benign]; RCV000034489.1 [benign]; RCV000035318.6 [benign]; RCV000132091.2 [benign]; RCV000144626.1 [benign]; 	CM092149 [CLASS=DP MUT=ALT PHEN="Colorectal cancer association with" GENE=MSH6]; 	COSM3749667	62	435	2	[2] old entry - no details available		NOC2L (inh=n/a pLI=0.00)
chr2	48030692	48030692	T	A	het	low_DP	QUAL=288;DP=17;AF=0.65;MQM=60	MSH6,FBXO11	synonymous_variant,downstream_gene_variant	MSH6:NM_000179.2:synonymous_variant:LOW:exon5/10:c.3306T>A:p.Thr1102Thr,MSH6:NM_001281492.1:synonymous_variant:LOW:exon3/8:c.2916T>A:p.Thr972Thr,MSH6:NM_001281493.1:synonymous_variant:LOW:exon4/9:c.2400T>A:p.Thr800Thr,MSH6:NM_001281494.1:synonymous_variant:LOW:exon5/10:c.2400T>A:p.Thr800Thr,FBXO11:NM_001190274.1:downstream_gene_variant:MODIFIER::c.*2857A>T:,FBXO11:NM_025133.4:downstream_gene_variant:MODIFIER::c.*2646A>T:		rs2020910	0.0493	0.02	0.02	0.0016				600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5|Endometrial cancer,familial|Mismatch repair cancer syndrome];				RCV000030267.3 [benign]; RCV000078313.4 [benign]; RCV000162391.1 [benign]; 			0	9				NOC2L (inh=n/a pLI=0.00)
chr2	215595164	215595164	G	A	het	pred_pathogenic_2	QUAL=334;DP=27;AF=0.44;MQM=60	BARD1	missense_variant,non_coding_exon_variant	BARD1:NM_000465.3:missense_variant:MODERATE:exon10/11:c.1972C>T:p.Arg658Cys,BARD1:NM_001282543.1:missense_variant:MODERATE:exon9/10:c.1915C>T:p.Arg639Cys,BARD1:NM_001282545.1:missense_variant:MODERATE:exon6/7:c.619C>T:p.Arg207Cys,BARD1:NM_001282548.1:missense_variant:MODERATE:exon5/6:c.562C>T:p.Arg188Cys,BARD1:NM_001282549.1:missense_variant:MODERATE:exon4/5:c.433C>T:p.Arg145Cys,BARD1:NR_104212.1:non_coding_exon_variant:MODIFIER:exon9/10:n.1965C>T:,BARD1:NR_104215.1:non_coding_exon_variant:MODIFIER:exon8/9:n.1908C>T:,BARD1:NR_104216.1:non_coding_exon_variant:MODIFIER:exon9/10:n.1164C>T:		rs3738888	0.0054	0.0079,0.0123	0.0079,0.0123	0.0078	5.1650	T	D,D,D,D	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];				RCV000130975.3 [benign]; 	CM067650 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=BARD1]; 	COSM3782110, COSM3782109	0	12			n/a (1xTP, 0xFP)	NOC2L (inh=n/a pLI=0.00)
chr2	215632255	215632255	C	T	het		QUAL=3342;DP=109;AF=0.55;MQM=60	BARD1	missense_variant,intron_variant,non_coding_exon_variant	BARD1:NM_000465.3:missense_variant:MODERATE:exon6/11:c.1519G>A:p.Val507Met,BARD1:NM_001282543.1:missense_variant:MODERATE:exon5/10:c.1462G>A:p.Val488Met,BARD1:NM_001282545.1:intron_variant:MODIFIER:exon2/6:c.216-14976G>A:,BARD1:NM_001282548.1:intron_variant:MODIFIER:exon1/5:c.159-14976G>A:,BARD1:NM_001282549.1:intron_variant:MODIFIER:exon3/4:c.364+24766G>A:,BARD1:NR_104212.1:non_coding_exon_variant:MODIFIER:exon5/10:n.1512G>A:,BARD1:NR_104215.1:non_coding_exon_variant:MODIFIER:exon4/9:n.1455G>A:,BARD1:NR_104216.1:non_coding_exon_variant:MODIFIER:exon5/10:n.711G>A:		rs2070094	0.3662	0.378	0.378	0.2758	-5.2640	T	T,T	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];				RCV000128872.2 [benign]; 	CM034384 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=BARD1]; 	COSM3757929, COSM3757930	192	669				KLHL17 (inh=n/a pLI=0.00)
chr2	215632256	215632256	A	G	hom		QUAL=3342;DP=109;AF=0.55;MQM=60	BARD1	synonymous_variant,intron_variant,non_coding_exon_variant	BARD1:NM_000465.3:synonymous_variant:LOW:exon6/11:c.1518T>C:p.His506His,BARD1:NM_001282543.1:synonymous_variant:LOW:exon5/10:c.1461T>C:p.His487His,BARD1:NM_001282545.1:intron_variant:MODIFIER:exon2/6:c.216-14977T>C:,BARD1:NM_001282548.1:intron_variant:MODIFIER:exon1/5:c.159-14977T>C:,BARD1:NM_001282549.1:intron_variant:MODIFIER:exon3/4:c.364+24765T>C:,BARD1:NR_104212.1:non_coding_exon_variant:MODIFIER:exon5/10:n.1511T>C:,BARD1:NR_104215.1:non_coding_exon_variant:MODIFIER:exon4/9:n.1454T>C:,BARD1:NR_104216.1:non_coding_exon_variant:MODIFIER:exon5/10:n.710T>C:		rs2070093	0.7706	0.813	0.813	0.7806				601593 [BARD1 (confirmed) Breast cancer,susceptibility to];				RCV000162380.1 [benign]; 			949	445				KLHL17 (inh=n/a pLI=0.00)
chr2	215645464	215645464	C	G	het		QUAL=1317;DP=79;AF=0.53;MQM=60	BARD1	missense_variant,intron_variant,non_coding_exon_variant	BARD1:NM_000465.3:missense_variant:MODERATE:exon4/11:c.1134G>C:p.Arg378Ser,BARD1:NM_001282543.1:missense_variant:MODERATE:exon3/10:c.1077G>C:p.Arg359Ser,BARD1:NM_001282545.1:intron_variant:MODIFIER:exon2/6:c.215+16321G>C:,BARD1:NM_001282548.1:intron_variant:MODIFIER:exon1/5:c.159-28185G>C:,BARD1:NM_001282549.1:intron_variant:MODIFIER:exon3/4:c.364+11557G>C:,BARD1:NR_104216.1:intron_variant:MODIFIER:exon3/9:n.507-11428G>C:,BARD1:NR_104212.1:non_coding_exon_variant:MODIFIER:exon3/10:n.1127G>C:,BARD1:NR_104215.1:non_coding_exon_variant:MODIFIER:exon2/9:n.1070G>C:		rs2229571	0.4593	0.548	0.548	0.6008	-0.6010	T	T,T	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];				RCV000132162.2 [benign]; 	CM076014 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1]; 	COSM3757932, COSM3757931	496	715				KLHL17 (inh=n/a pLI=0.00)
chr2	215674224	215674224	G	A	het	pred_pathogenic_1	QUAL=10769;DP=775;AF=0.49;MQM=60	BARD1,LOC101928103	missense_variant,upstream_gene,non_coding_exon_variant	BARD1:NM_000465.3:missense_variant:MODERATE:exon1/11:c.70C>T:p.Pro24Ser,BARD1:NM_001282543.1:missense_variant:MODERATE:exon1/10:c.70C>T:p.Pro24Ser,BARD1:NM_001282545.1:missense_variant:MODERATE:exon1/7:c.70C>T:p.Pro24Ser,BARD1:NM_001282548.1:missense_variant:MODERATE:exon1/6:c.70C>T:p.Pro24Ser,BARD1:NM_001282549.1:missense_variant:MODERATE:exon1/5:c.70C>T:p.Pro24Ser,LOC101928103:NR_110292.1:upstream_gene:MODIFIER::n.-1G>A:,BARD1:NR_104212.1:non_coding_exon_variant:MODIFIER:exon1/10:n.212C>T:,BARD1:NR_104215.1:non_coding_exon_variant:MODIFIER:exon1/9:n.212C>T:,BARD1:NR_104216.1:non_coding_exon_variant:MODIFIER:exon1/10:n.212C>T:		rs1048108	0.3313	0.367	0.367	0.3474	0.9680	T	T,D	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];				RCV000162363.1 [benign]; 	CM076015 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1]; 	COSM442275, COSM1482743	191	693				KLHL17 (inh=n/a pLI=0.00)
chr2	220416942	220416942	G	C	hom		QUAL=1037;DP=33;AF=1.00;MQM=60	OBSL1,MIR3132,TMEM198	splice_region_variant&intron_variant,upstream_gene,downstream_gene_variant	OBSL1:NM_015311.2:splice_region_variant&intron_variant:LOW:exon18/20:c.5309-4C>G:,MIR3132:NR_036082.1:upstream_gene:MODIFIER::n.-1C>G:,TMEM198:NM_001005209.1:downstream_gene_variant:MODIFIER::c.*1477G>C:,OBSL1:NM_001173431.1:downstream_gene_variant:MODIFIER::c.*4946C>G:		rs34490902	0.3876	0.409	0.409	0.4551				610991 [OBSL1 (confirmed) 3-M syndrome 2];				RCV000175465.1 [benign]; 			230	622				KLHL17 (inh=n/a pLI=0.00)
chr2	220417266	220417266	C	T	hom	pred_pathogenic_3	QUAL=4444;DP=146;AF=1.00;MQM=60	OBSL1,MIR3132,TMEM198	missense_variant,upstream_gene,downstream_gene_variant	OBSL1:NM_015311.2:missense_variant:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln,MIR3132:NR_036082.1:upstream_gene:MODIFIER::n.-1G>A:,TMEM198:NM_001005209.1:downstream_gene_variant:MODIFIER::c.*1477C>T:,OBSL1:NM_001173431.1:downstream_gene_variant:MODIFIER::c.*4946G>A:		rs59332477	0.3766	0.416	0.416	0.4456	3.5850	T	D,T	610991 [OBSL1 (confirmed) 3-M syndrome 2];						COSM3757971	226	620				KLHL17 (inh=n/a pLI=0.00)
chr2	220419236	220419236	T	C	hom		QUAL=14166;DP=460;AF=1.00;MQM=60	OBSL1,TMEM198	synonymous_variant,downstream_gene_variant	OBSL1:NM_015311.2:synonymous_variant:LOW:exon15/21:c.4836A>G:p.Thr1612Thr,TMEM198:NM_001005209.1:downstream_gene_variant:MODIFIER::c.*1477T>C:,OBSL1:NM_001173431.1:downstream_gene_variant:MODIFIER::c.*4946A>G:		rs10932813	0.9852	0.996	0.996	0.9996				610991 [OBSL1 (confirmed) 3-M syndrome 2];							1297	2				KLHL17 (inh=n/a pLI=0.00)
chr2	220419339	220419339	T	C	hom		QUAL=21464;DP=685;AF=1.00;MQM=60	OBSL1,TMEM198	missense_variant,downstream_gene_variant	OBSL1:NM_015311.2:missense_variant:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg,TMEM198:NM_001005209.1:downstream_gene_variant:MODIFIER::c.*1477T>C:,OBSL1:NM_001173431.1:downstream_gene_variant:MODIFIER::c.*4946A>G:		rs10932814	0.9611	0.985	0.985	0.9925	0.1950	T	T,T	610991 [OBSL1 (confirmed) 3-M syndrome 2];							1290	9				KLHL17 (inh=n/a pLI=0.00)
chr2	220420956	220420956	A	G	hom	pred_pathogenic_1	QUAL=1332;DP=50;AF=1.00;MQM=60	OBSL1	synonymous_variant	OBSL1:NM_015311.2:synonymous_variant:LOW:exon14/21:c.4395T>C:p.Asp1465Asp,OBSL1:NM_001173431.1:synonymous_variant:LOW:exon14/14:c.4395T>C:p.Asp1465Asp		rs10932816	0.9637	0.989	0.989	0.9996	-3.7700	T	D,.	610991 [OBSL1 (confirmed) 3-M syndrome 2];						COSM4133493	1305	3				KLHL17 (inh=n/a pLI=0.00)
chr2	220421417	220421417	C	G	hom		QUAL=23326;DP=726;AF=1.00;MQM=60	OBSL1	missense_variant	OBSL1:NM_015311.2:missense_variant:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp,OBSL1:NM_001173431.1:missense_variant:MODERATE:exon13/14:c.4095G>C:p.Glu1365Asp		rs1983210	0.7246	0.74	0.74	0.7336	0.9020	T,T	T,T,T,T,.	610991 [OBSL1 (confirmed) 3-M syndrome 2];						COSM442368	758	478				KLHL17 (inh=n/a pLI=0.00)
chr2	220422686	220422686	C	T	het	pred_pathogenic_2	QUAL=700;DP=62;AF=0.44;MQM=60	OBSL1	missense_variant,downstream_gene_variant	OBSL1:NM_015311.2:missense_variant:MODERATE:exon11/21:c.3649G>A:p.Glu1217Lys,OBSL1:NM_001173431.1:missense_variant:MODERATE:exon11/14:c.3649G>A:p.Glu1217Lys,OBSL1:NM_001173408.1:downstream_gene_variant:MODIFIER::c.*3392G>A:		rs72957510	0.007	0.0234,0.0055	0.0234,0.0055	0.0055	0.5010	T	T,D,T,T	610991 [OBSL1 (confirmed) 3-M syndrome 2];				RCV000174131.1 [benign]; 			2	26				KLHL17 (inh=n/a pLI=0.00)
chr2	220422774	220422774	A	G	hom		QUAL=23920;DP=748;AF=1.00;MQM=60	OBSL1	synonymous_variant,downstream_gene_variant	OBSL1:NM_015311.2:synonymous_variant:LOW:exon11/21:c.3561T>C:p.Pro1187Pro,OBSL1:NM_001173431.1:synonymous_variant:LOW:exon11/14:c.3561T>C:p.Pro1187Pro,OBSL1:NM_001173408.1:downstream_gene_variant:MODIFIER::c.*3392T>C:		rs2278201	0.4191	0.429	0.429	0.4331	-4.6180	T		610991 [OBSL1 (confirmed) 3-M syndrome 2];						COSM3757974	210	630				KLHL17 (inh=n/a pLI=0.00)
chr2	220430203	220430203	C	T	hom		QUAL=23625;DP=730;AF=1.00;MQM=60	OBSL1	missense_variant	OBSL1:NM_015311.2:missense_variant:MODERATE:exon6/21:c.2168G>A:p.Arg723Lys,OBSL1:NM_001173431.1:missense_variant:MODERATE:exon6/14:c.2168G>A:p.Arg723Lys,OBSL1:NM_001173408.1:missense_variant:MODERATE:exon6/9:c.2168G>A:p.Arg723Lys		rs1039898	0.7927	0.865	0.865	0.9043	-0.1200	T	T,T,T,T,T	610991 [OBSL1 (confirmed) 3-M syndrome 2];						COSM4133496, COSM4133495	1043	236				PLEKHN1 (inh=n/a pLI=0.00)
chr2	220435034	220435034	A	G	hom		QUAL=20225;DP=634;AF=1.00;MQM=60	OBSL1,INHA	synonymous_variant,upstream_gene	OBSL1:NM_015311.2:synonymous_variant:LOW:exon1/21:c.921T>C:p.Leu307Leu,OBSL1:NM_001173431.1:synonymous_variant:LOW:exon1/14:c.921T>C:p.Leu307Leu,OBSL1:NM_001173408.1:synonymous_variant:LOW:exon1/9:c.921T>C:p.Leu307Leu,INHA:NM_002191.3:upstream_gene:MODIFIER::c.-144A>G:		rs10180675	0.7833	0.861	0.861	0.9044				610991 [OBSL1 (confirmed) 3-M syndrome 2];				RCV000173448.1 [benign]; 		COSM4133504, COSM4133503	1045	233				PLEKHN1 (inh=n/a pLI=0.00)
chr2	220435375	220435375	G	A	het	low_DP	QUAL=387;DP=18;AF=0.83;MQM=60	OBSL1,INHA	synonymous_variant,upstream_gene	OBSL1:NM_015311.2:synonymous_variant:LOW:exon1/21:c.580C>T:p.Leu194Leu,OBSL1:NM_001173431.1:synonymous_variant:LOW:exon1/14:c.580C>T:p.Leu194Leu,OBSL1:NM_001173408.1:synonymous_variant:LOW:exon1/9:c.580C>T:p.Leu194Leu,INHA:NM_002191.3:upstream_gene:MODIFIER::c.-144G>A:		rs1061399	0.3588	0.261	0.261	0.3695				610991 [OBSL1 (confirmed) 3-M syndrome 2];						COSM4133505, COSM442371	260	589				PLEKHN1 (inh=n/a pLI=0.00)
chr3	10085536	10085536	A	G	het		QUAL=3006;DP=292;AF=0.43;MQM=60	FANCD2	synonymous_variant	FANCD2:NM_033084.3:synonymous_variant:LOW:exon14/43:c.1122A>G:p.Val374Val,FANCD2:NM_001018115.1:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374Val		rs34046352	0	0.122	0.122	0				613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];						COSM3759562, COSM3759563	0	474				PLEKHN1 (inh=n/a pLI=0.00)
chr3	10088404	10088404	C	T	het	low_MQM	QUAL=512;DP=113;AF=0.20;MQM=17	FANCD2	synonymous_variant	FANCD2:NM_033084.3:synonymous_variant:LOW:exon15/43:c.1275C>T:p.Tyr425Tyr,FANCD2:NM_001018115.1:synonymous_variant:LOW:exon15/44:c.1275C>T:p.Tyr425Tyr			0	0.054	0.054	0				613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];						COSM1417229, COSM1417230	0	956				PLEKHN1 (inh=n/a pLI=0.00)
chr3	10088408	10088408	G	-	het	low_MQM;anno_high_impact	QUAL=512;DP=113;AF=0.20;MQM=17	FANCD2	splice_donor_variant	FANCD2:NM_033084.3:splice_donor_variant:HIGH:exon15/42:c.1278+1delG:,FANCD2:NM_001018115.1:splice_donor_variant:HIGH:exon15/43:c.1278+1delG:			0	0.036	0.036	0.1616				613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];						COSM1417231, COSM1417232	0	917	1	[1] Ute Grasshoff 22.04.2015		PERM1 (inh=n/a pLI=n/a)
chr3	10088410	10088412	AAG	-	het	low_MQM	QUAL=512;DP=113;AF=0.20;MQM=17	FANCD2	splice_region_variant&intron_variant	FANCD2:NM_033084.3:splice_region_variant&intron_variant:LOW:exon15/42:c.1278+3_1278+5delAAG:,FANCD2:NM_001018115.1:splice_region_variant&intron_variant:LOW:exon15/43:c.1278+3_1278+5delAAG:		rs375350046	0	0.036	0.036	0				613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];							0	917				PERM1 (inh=n/a pLI=n/a)
chr3	10089723	10089723	G	A	het	low_MQM	QUAL=817;DP=147;AF=0.22;MQM=35	FANCD2	synonymous_variant	FANCD2:NM_033084.3:synonymous_variant:LOW:exon16/43:c.1401G>A:p.Thr467Thr,FANCD2:NM_001018115.1:synonymous_variant:LOW:exon16/44:c.1401G>A:p.Thr467Thr		rs12330369	0	0.446	0.446	0				613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];						COSM4157098, COSM4157099	0	1215				PERM1 (inh=n/a pLI=n/a)
chr3	10089738	10089738	A	G	het	low_MQM	QUAL=571;DP=119;AF=0.22;MQM=29	FANCD2	splice_region_variant&intron_variant	FANCD2:NM_033084.3:splice_region_variant&intron_variant:LOW:exon16/42:c.1413+3A>G:,FANCD2:NM_001018115.1:splice_region_variant&intron_variant:LOW:exon16/43:c.1413+3A>G:		rs62245508	0	0.437	0.437	0				613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];							0	1211	1	[1] old entry - no details available	n/a (1xTP, 0xFP)	PERM1 (inh=n/a pLI=n/a)
chr3	10091153	10091153	C	T	het	low_MQM	QUAL=126;DP=63;AF=0.17;MQM=40	FANCD2	synonymous_variant	FANCD2:NM_033084.3:synonymous_variant:LOW:exon17/43:c.1509C>T:p.Asn503Asn,FANCD2:NM_001018115.1:synonymous_variant:LOW:exon17/44:c.1509C>T:p.Asn503Asn		rs35652360	0	0.014	0.014	0				613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];							10	247				PERM1 (inh=n/a pLI=n/a)
chr3	10106532	10106532	C	T	het		QUAL=1466;DP=74;AF=0.64;MQM=60	FANCD2	missense_variant	FANCD2:NM_033084.3:missense_variant:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu,FANCD2:NM_001018115.1:missense_variant:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu		rs3864017	0	0.155	0.155	0	-0.1810	T	T,T,T,T	613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				RCV000120989.1 [not provided]; 			32	430				PERM1 (inh=n/a pLI=n/a)
chr3	10138069	10138069	T	G	het		QUAL=11320;DP=767;AF=0.47;MQM=60	FANCD2,FANCD2OS	synonymous_variant,intron_variant	FANCD2:NM_033084.3:synonymous_variant:LOW:exon42/43:c.4098T>G:p.Leu1366Leu,FANCD2:NM_001018115.1:synonymous_variant:LOW:exon42/44:c.4098T>G:p.Leu1366Leu,FANCD2OS:NM_173472.1:intron_variant:MODIFIER:exon2/2:c.*43+7813A>C:		rs2272125	0.2422	0.187	0.187	0.1647				613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];					CM066071 [CLASS=DP MUT=ALT PHEN="Breast cancer increased risk association with" GENE=FANCD2]; 	COSM3759565, COSM3759566	42	444				PERM1 (inh=n/a pLI=n/a)
chr3	142168331	142168331	C	T	hom		QUAL=1580;DP=48;AF=1.00;MQM=60	ATR,XRN1	synonymous_variant,upstream_gene	ATR:NM_001184.3:synonymous_variant:LOW:exon47/47:c.7875G>A:p.Gln2625Gln,XRN1:NM_019001.4:upstream_gene:MODIFIER::c.-119G>A:,XRN1:NM_001282857.1:upstream_gene:MODIFIER::c.-119G>A:,XRN1:NM_001282859.1:upstream_gene:MODIFIER::c.-119G>A:		rs1802904	0.9163	0.865	0.865	0.8614				601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];				RCV000079601.6 [other]; 			1189	373				PERM1 (inh=n/a pLI=n/a)
chr3	142178144	142178144	C	T	het		QUAL=1272;DP=77;AF=0.55;MQM=60	ATR	missense_variant	ATR:NM_001184.3:missense_variant:MODERATE:exon43/47:c.7274G>A:p.Arg2425Gln		rs2229032	0.1022	0.132	0.132	0.1578	0.0440	T	T,T	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];				RCV000123787.1 [benign]; RCV000145330.1 [benign]; 		COSM149485	37	414				HES4 (inh=n/a pLI=0.00)
chr3	142188337	142188337	A	C	het	pred_pathogenic_1	QUAL=11942;DP=680;AF=0.56;MQM=60	ATR	missense_variant	ATR:NM_001184.3:missense_variant:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp		rs28910273	0.002	0.0033	0.0033	0.0069	2.3460	T	T,D	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];				RCV000145327.1 [uncertain significance]; 			0	17				ISG15 (inh=AR pLI=0.01)
chr3	142217537	142217537	A	G	het		QUAL=4602;DP=347;AF=0.51;MQM=60	ATR	synonymous_variant	ATR:NM_001184.3:synonymous_variant:LOW:exon32/47:c.5460T>C:p.Tyr1820Tyr		rs2227932	0.0669	0.093	0.093	0.1062				601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];				RCV000123788.1 [benign]; RCV000145320.1 [likely benign]; 			19	255				ISG15 (inh=AR pLI=0.01)
chr3	142277575	142277575	A	T	het		QUAL=3913;DP=267;AF=0.46;MQM=60	ATR	synonymous_variant	ATR:NM_001184.3:synonymous_variant:LOW:exon8/47:c.1776T>A:p.Gly592Gly		rs2227930	0.598	0.553	0.553	0.595				601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];				RCV000145291.5 [other]; 		COSM149486	550	763				ISG15 (inh=AR pLI=0.01)
chr3	142281612	142281612	A	G	het		QUAL=8098;DP=524;AF=0.48;MQM=60	ATR	missense_variant	ATR:NM_001184.3:missense_variant:MODERATE:exon4/47:c.632T>C:p.Met211Thr		rs2227928	0.5974	0.552	0.552	0.5955	1.2730	T	T,T	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];				RCV000079600.6 [other]; 		COSM149487	550	762				ISG15 (inh=AR pLI=0.01), AGRN (inh=AR pLI=0.17)
chr5	79950781	79950781	A	G	het		QUAL=526;DP=38;AF=0.47;MQM=60	MSH3,DHFR,MTRNR2L2	missense_variant&splice_region_variant,5_prime_UTR_variant,upstream_gene,non_coding_exon_variant	MSH3:NM_002439.4:missense_variant&splice_region_variant:MODERATE:exon1/24:c.235A>G:p.Ile79Val,DHFR:NM_000791.3:5_prime_UTR_variant:MODIFIER:exon1/6:c.-473T>C:,DHFR:NM_001290354.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-579T>C:,DHFR:NM_001290357.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-473T>C:,MTRNR2L2:NM_001190470.1:upstream_gene:MODIFIER::c.-950T>C:,DHFR:NR_110936.1:non_coding_exon_variant:MODIFIER:exon1/4:n.20T>C:		rs1650697	0.7686	0.854	0.854	0	-0.4930	T	T,T	126060 [DHFR (confirmed) Megaloblastic anemia due to dihydrofolate reductase deficiency]:600887 [MSH3 (provisional) Endometrial carcinoma,somatic];					CM003459 [CLASS=DP MUT=REF PHEN="Colon cancer association with" GENE=MSH3]; 	COSM4160035	797	497				AGRN (inh=AR pLI=0.17)
chr5	80149981	80149981	A	G	hom		QUAL=27953;DP=894;AF=1.00;MQM=60	MSH3	missense_variant	MSH3:NM_002439.4:missense_variant:MODERATE:exon21/24:c.2846A>G:p.Gln949Arg		rs184967	0.9022	0.873	0.873	0.8355	0.4010	T	T,T	600887 [MSH3 (provisional) Endometrial carcinoma,somatic];					CM076322 [CLASS=DP MUT=REF PHEN="Proximal colon cancer increased risk association with" GENE=MSH3]; 	COSM4160036	987	403				AGRN (inh=AR pLI=0.17)
chr5	80168937	80168937	G	A	hom		QUAL=3734;DP=111;AF=1.00;MQM=60	MSH3	missense_variant&splice_region_variant	MSH3:NM_002439.4:missense_variant&splice_region_variant:MODERATE:exon23/24:c.3133G>A:p.Ala1045Thr		rs26279	0.7202	0.73	0.73	0.7094	1.0140	T	T,T	600887 [MSH3 (provisional) Endometrial carcinoma,somatic];					CM076321 [CLASS=DP MUT=REF PHEN="Colorectal cancer increased risk association with" GENE=MSH3]; 		697	591				AGRN (inh=AR pLI=0.17)
chr5	112162854	112162854	T	C	het		QUAL=2153;DP=181;AF=0.41;MQM=60	APC	synonymous_variant	APC:NM_000038.5:synonymous_variant:LOW:exon12/16:c.1458T>C:p.Tyr486Tyr,APC:NM_001127511.2:synonymous_variant:LOW:exon10/14:c.1404T>C:p.Tyr468Tyr,APC:NM_001127510.2:synonymous_variant:LOW:exon13/17:c.1458T>C:p.Tyr486Tyr		rs2229992	0.51	0.577	0.577	0.5902				611731 [APC (confirmed) Adenomatous polyposis coli|Gastric cancer,somatic|Adenoma,periampullary,somatic|Hepatoblastoma,somatic|Desmoid disease,hereditary|Colorectal cancer,somatic|Brain tumor-polyposis syndrome 2|Gardner syndrome];				RCV000035064.6 [benign]; RCV000074147.1 [other]; RCV000131423.2 [benign]; 		COSM1432175	497	709	1	[1] old entry - no details available		AGRN (inh=AR pLI=0.17)
chr5	112164561	112164561	G	A	het		QUAL=3031;DP=177;AF=0.51;MQM=60	APC	synonymous_variant	APC:NM_000038.5:synonymous_variant:LOW:exon14/16:c.1635G>A:p.Ala545Ala,APC:NM_001127511.2:synonymous_variant:LOW:exon12/14:c.1581G>A:p.Ala527Ala,APC:NM_001127510.2:synonymous_variant:LOW:exon15/17:c.1635G>A:p.Ala545Ala		rs351771	0.6661	0.648	0.648	0.6169				611731 [APC (confirmed) Adenomatous polyposis coli|Gastric cancer,somatic|Adenoma,periampullary,somatic|Hepatoblastoma,somatic|Desmoid disease,hereditary|Colorectal cancer,somatic|Brain tumor-polyposis syndrome 2|Gardner syndrome];				RCV000035066.6 [benign]; RCV000074153.1 [other]; RCV000162371.1 [benign]; 		COSM3760868	563	672	1	[1] old entry - no details available		AGRN (inh=AR pLI=0.17)
chr5	112175770	112175770	G	A	het		QUAL=6385;DP=417;AF=0.49;MQM=60	APC	synonymous_variant	APC:NM_000038.5:synonymous_variant:LOW:exon16/16:c.4479G>A:p.Thr1493Thr,APC:NM_001127511.2:synonymous_variant:LOW:exon14/14:c.4425G>A:p.Thr1475Thr,APC:NM_001127510.2:synonymous_variant:LOW:exon17/17:c.4479G>A:p.Thr1493Thr		rs41115	0.6655	0.648	0.648	0.6167				611731 [APC (confirmed) Adenomatous polyposis coli|Gastric cancer,somatic|Adenoma,periampullary,somatic|Hepatoblastoma,somatic|Desmoid disease,hereditary|Colorectal cancer,somatic|Brain tumor-polyposis syndrome 2|Gardner syndrome];				RCV000035071.6 [benign]; RCV000074234.1 [other]; RCV000162372.1 [benign]; 		COSM3760869	566	674	1	[1] old entry - no details available		AGRN (inh=AR pLI=0.17)
chr5	112176325	112176325	G	A	het		QUAL=303;DP=25;AF=0.52;MQM=60	APC	synonymous_variant	APC:NM_000038.5:synonymous_variant:LOW:exon16/16:c.5034G>A:p.Gly1678Gly,APC:NM_001127511.2:synonymous_variant:LOW:exon14/14:c.4980G>A:p.Gly1660Gly,APC:NM_001127510.2:synonymous_variant:LOW:exon17/17:c.5034G>A:p.Gly1678Gly		rs42427	0.6667	0.65	0.65	0.621				611731 [APC (confirmed) Adenomatous polyposis coli|Gastric cancer,somatic|Adenoma,periampullary,somatic|Hepatoblastoma,somatic|Desmoid disease,hereditary|Colorectal cancer,somatic|Brain tumor-polyposis syndrome 2|Gardner syndrome];				RCV000035074.6 [benign]; RCV000074235.1 [other]; RCV000162373.1 [benign]; 		COSM3760870	569	664	1	[1] old entry - no details available		AGRN (inh=AR pLI=0.17)
chr5	112176559	112176559	T	G	het		QUAL=4013;DP=259;AF=0.49;MQM=60	APC	synonymous_variant	APC:NM_000038.5:synonymous_variant:LOW:exon16/16:c.5268T>G:p.Ser1756Ser,APC:NM_001127511.2:synonymous_variant:LOW:exon14/14:c.5214T>G:p.Ser1738Ser,APC:NM_001127510.2:synonymous_variant:LOW:exon17/17:c.5268T>G:p.Ser1756Ser		rs866006	0.6669	0.65	0.65	0.6186				611731 [APC (confirmed) Adenomatous polyposis coli|Gastric cancer,somatic|Adenoma,periampullary,somatic|Hepatoblastoma,somatic|Desmoid disease,hereditary|Colorectal cancer,somatic|Brain tumor-polyposis syndrome 2|Gardner syndrome];				RCV000166360.1,RCV000035076.6 [likely benign,benign]; RCV000074236.1 [other]; RCV000162374.1 [benign]; 			565	660	1	[1] old entry - no details available		AGRN (inh=AR pLI=0.17)
chr5	112176756	112176756	T	A	het		QUAL=5320;DP=367;AF=0.45;MQM=60	APC	missense_variant	APC:NM_000038.5:missense_variant:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp,APC:NM_001127511.2:missense_variant:MODERATE:exon14/14:c.5411T>A:p.Val1804Asp,APC:NM_001127510.2:missense_variant:MODERATE:exon17/17:c.5465T>A:p.Val1822Asp		rs459552	0.8654	0.798	0.798	0.765	3.6530	T	T,T,T	611731 [APC (confirmed) Adenomatous polyposis coli|Gastric cancer,somatic|Adenoma,periampullary,somatic|Hepatoblastoma,somatic|Desmoid disease,hereditary|Colorectal cancer,somatic|Brain tumor-polyposis syndrome 2|Gardner syndrome];				RCV000020089.2 [benign]; RCV000034393.1 [benign]; RCV000035078.7 [benign]; RCV000074239.1 [other]; RCV000132160.2 [benign]; 	CM990164 [CLASS=DP MUT=REF PHEN="Adenomatous polyposis coli association with" GENE=APC]; 	COSM3760871	873	502	1	[1] old entry - no details available		AGRN (inh=AR pLI=0.17)
chr5	112177171	112177171	G	A	het		QUAL=12273;DP=804;AF=0.48;MQM=60	APC	synonymous_variant	APC:NM_000038.5:synonymous_variant:LOW:exon16/16:c.5880G>A:p.Pro1960Pro,APC:NM_001127511.2:synonymous_variant:LOW:exon14/14:c.5826G>A:p.Pro1942Pro,APC:NM_001127510.2:synonymous_variant:LOW:exon17/17:c.5880G>A:p.Pro1960Pro		rs465899	0.6665	0.648	0.648	0.6168				611731 [APC (confirmed) Adenomatous polyposis coli|Gastric cancer,somatic|Adenoma,periampullary,somatic|Hepatoblastoma,somatic|Desmoid disease,hereditary|Colorectal cancer,somatic|Brain tumor-polyposis syndrome 2|Gardner syndrome];				RCV000035080.6 [benign]; RCV000074242.1 [other]; RCV000162375.1 [benign]; 		COSM3760872	564	672	1	[1] old entry - no details available		AGRN (inh=AR pLI=0.17)
chr5	131925483	131925483	G	C	het		QUAL=1006;DP=67;AF=0.49;MQM=60	RAD50	missense_variant	RAD50:NM_005732.3:missense_variant:MODERATE:exon9/25:c.1406G>C:p.Gly469Ala		rs55653181	0.0002	0.0001	0.0001	0	6.3310	T	T,T,T	604040 [RAD50 (provisional) Nijmegen breakage syndrome-like disorder];							0	0				AGRN (inh=AR pLI=0.17)
chr6	35423662	35423662	A	C	het		QUAL=1125;DP=96;AF=0.40;MQM=60	FANCE	synonymous_variant	FANCE:NM_021922.2:synonymous_variant:LOW:exon2/10:c.387A>C:p.Pro129Pro		rs4713867	0.778	0.721	0.721	0.6717				613976 [FANCE (provisional) Fanconi anemia,complementation group E];							719	701				AGRN (inh=AR pLI=0.17)
chr7	6026775	6026775	T	C	hom	anno_pathogenic_hgmd	QUAL=524;DP=21;AF=1.00;MQM=59	PMS2	missense_variant,non_coding_exon_variant	PMS2:NM_000535.5:missense_variant:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu,PMS2:NR_003085.2:non_coding_exon_variant:MODIFIER:exon11/15:n.1703A>G:		rs2228006	0.8832	0.851	0.851	0.8457	1.4430	T	T,T,T,T	600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];				RCV000030365.3 [benign]; RCV000034619.2,RCV000121840.3 [benign,benign]; 	BM1497492 [CLASS=DM? MUT=REF PHEN="Colorectal cancer non-polyposis" GENE=PMS2]; 	COSM4162329	1206	397	1	[1] Tanja Benkert 16.04.2015		AGRN (inh=AR pLI=0.17)
chr7	6036980	6036980	G	C	hom		QUAL=714;DP=22;AF=1.00;MQM=60	PMS2	synonymous_variant,non_coding_exon_variant	PMS2:NM_000535.5:synonymous_variant:LOW:exon7/15:c.780C>G:p.Ser260Ser,PMS2:NR_003085.2:non_coding_exon_variant:MODIFIER:exon7/15:n.862C>G:		rs1805319	0.8313	0.809	0.809	0.8148				600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];				RCV000162392.1,RCV000030372.3 [benign,benign]; RCV000079112.4 [benign]; RCV000131484.2 [benign]; 		COSM4162330	1111	467				AGRN (inh=AR pLI=0.17)
chr7	6037057	6037057	-	A	het		QUAL=285;DP=23;AF=0.48;MQM=60	PMS2	splice_region_variant&intron_variant	PMS2:NM_000535.5:splice_region_variant&intron_variant:LOW:exon6/14:c.706-4_706-3insT:,PMS2:NR_003085.2:splice_region_variant&intron_variant:LOW:exon6/14:n.788-4_788-3insT:		rs570998668	0	0	0	0				600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];				RCV000179768.1 [benign]; 		COSM1735804	0	145				AGRN (inh=AR pLI=0.17)
chr7	128846328	128846328	G	C	hom		QUAL=28334;DP=899;AF=1.00;MQM=60	SMO	synonymous_variant	SMO:NM_005631.4:synonymous_variant:LOW:exon6/12:c.1164G>C:p.Gly388Gly		rs2228617	0.7562	0.797	0.797	0.8391				601500 [SMO (provisional) Basal cell carcinoma,somatic];						COSM4004294	819	228				AGRN (inh=AR pLI=0.17)
chr7	142460313	142460313	T	C	hom		QUAL=4873;DP=163;AF=0.99;MQM=60	PRSS1	synonymous_variant	PRSS1:NM_002769.4:synonymous_variant:LOW:exon4/5:c.486T>C:p.Asp162Asp		rs6666	0.3966	0.369	0.369	0				276000 [PRSS1 (confirmed) Pancreatitis,hereditary|Trypsinogen deficiency];					CM086253 [CLASS=DP MUT=REF PHEN="Pancreatitis chronic association with" GENE=PRSS1]; 	COSM4161889	157	933				AGRN (inh=AR pLI=0.17)
chr7	142460865	142460865	T	C	hom		QUAL=10084;DP=347;AF=1.00;MQM=59	PRSS1	synonymous_variant	PRSS1:NM_002769.4:synonymous_variant:LOW:exon5/5:c.738T>C:p.Asn246Asn		rs6667	0.3938	0.504	0.504	0				276000 [PRSS1 (confirmed) Pancreatitis,hereditary|Trypsinogen deficiency];							443	685				AGRN (inh=AR pLI=0.17)
chr8	90958422	90958422	T	C	het		QUAL=708;DP=46;AF=0.54;MQM=60	NBN	synonymous_variant	NBN:NM_002485.4:synonymous_variant:LOW:exon13/16:c.2016A>G:p.Pro672Pro		rs1061302	0.3528	0.345	0.345	0.3132				602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];				RCV000162357.1 [benign]; 		COSM3763441	179	733	1	[1] Alexandra Doehring 27.08.2015		AGRN (inh=AR pLI=0.17)
chr8	90958530	90958530	T	C	het		QUAL=476;DP=35;AF=0.46;MQM=60	NBN	splice_region_variant&intron_variant	NBN:NM_002485.4:splice_region_variant&intron_variant:LOW:exon12/15:c.1915-7A>G:		rs2308962	0.379	0.353	0.353	0.3144				602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];							178	737	1	[1] Alexandra Doehring 27.08.2015		AGRN (inh=AR pLI=0.17)
chr8	90967711	90967711	A	G	het		QUAL=435;DP=36;AF=0.42;MQM=60	NBN	synonymous_variant	NBN:NM_002485.4:synonymous_variant:LOW:exon10/16:c.1197T>C:p.Asp399Asp		rs709816	0.6086	0.467	0.467	0.3559				602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];				RCV000162376.1 [benign]; RCV000173761.1 [benign]; 		COSM3763442	224	786	1	[1] Alexandra Doehring 27.08.2015		AGRN (inh=AR pLI=0.17), RP11-54O7.14 (inh=n/a pLI=n/a)
chr8	90990479	90990479	C	G	het		QUAL=13193;DP=820;AF=0.50;MQM=60	NBN	missense_variant	NBN:NM_002485.4:missense_variant:MODERATE:exon5/16:c.553G>C:p.Glu185Gln		rs1805794	0.357	0.345	0.345	0.3136	2.1330	T	T,T,T,T	602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];				RCV000121620.2 [benign]; RCV000162358.1 [benign]; 	CM034886 [CLASS=DP MUT=ALT PHEN="Lung cancer association with" GENE=NBN]; 	COSM3763443	175	737	1	[1] Christopher Schroeder 27.04.2015		RNF223 (inh=n/a pLI=n/a)
chr8	90995019	90995019	C	T	het	low_DP	QUAL=148;DP=18;AF=0.39;MQM=60	NBN	synonymous_variant	NBN:NM_002485.4:synonymous_variant:LOW:exon2/16:c.102G>A:p.Leu34Leu		rs1063045	0.3792	0.353	0.353	0.3147				602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];				RCV000162359.1 [benign]; 		COSM3763444	180	716	1	[1] Alexandra Doehring 27.08.2015		RNF223 (inh=n/a pLI=n/a)
chr9	17273878	17273878	A	G	het		QUAL=1290;DP=63;AF=0.71;MQM=60	CNTLN	splice_region_variant&intron_variant	CNTLN:NM_017738.3:splice_region_variant&intron_variant:LOW:exon6/25:c.983+14A>G:,CNTLN:NM_001114395.2:splice_region_variant&intron_variant:LOW:exon6/6:c.983+14A>G:		rs12376938	0.2258	0.253	0.253	0.2651											66	304				C1orf159 (inh=n/a pLI=0.09)
chr9	17342383	17342383	C	T	hom		QUAL=984;DP=30;AF=1.00;MQM=60	CNTLN	synonymous_variant	CNTLN:NM_017738.3:synonymous_variant:LOW:exon12/26:c.1827C>T:p.Asp609Asp		rs1442527	0.9495	0.986	0.986	0.9994											1032	2				C1orf159 (inh=n/a pLI=0.09)
chr9	17394536	17394536	C	T	hom		QUAL=1755;DP=55;AF=1.00;MQM=60	CNTLN	missense_variant	CNTLN:NM_017738.3:missense_variant:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile		rs7035276	0.7806	0.822	0.822	0.8763	0.3250	T	T,T,T								770	229				RP11-465B22.5 (inh=n/a pLI=n/a)
chr9	17394996	17394996	T	C	hom		QUAL=3134;DP=97;AF=1.00;MQM=60	CNTLN	synonymous_variant	CNTLN:NM_017738.3:synonymous_variant:LOW:exon15/26:c.2544T>C:p.His848His		rs3739489	0.8411	0.879	0.879	0.9149											873	157				SDF4 (inh=n/a pLI=0.00)
chr9	17409366	17409366	G	A	hom		QUAL=12093;DP=378;AF=1.00;MQM=60	CNTLN	synonymous_variant	CNTLN:NM_017738.3:synonymous_variant:LOW:exon16/26:c.2691G>A:p.Thr897Thr		rs2780211	0.8389	0.875	0.875	0.9115										COSM3982792	864	165				UBE2J2 (inh=n/a pLI=0.42)
chr9	17457513	17457513	A	-	hom	low_DP	QUAL=104;DP=4;AF=1.00;MQM=60	CNTLN	splice_region_variant&intron_variant	CNTLN:NM_017738.3:splice_region_variant&intron_variant:LOW:exon18/25:c.3115-9delA:	(TATATT)n	rs397766990	0.7342	0	0	0.9938											719	133				ACAP3 (inh=n/a pLI=0.04)
chr9	21971137	21971137	T	G	het	pred_pathogenic_4	QUAL=404;DP=50;AF=0.46;MQM=60	CDKN2A,C9orf53	missense_variant,synonymous_variant,3_prime_UTR_variant,downstream_gene_variant	CDKN2A:NM_001195132.1:missense_variant:MODERATE:exon2/4:c.221A>C:p.Asp74Ala,CDKN2A:NM_000077.4:missense_variant:MODERATE:exon2/3:c.221A>C:p.Asp74Ala,CDKN2A:NM_058195.3:synonymous_variant:LOW:exon2/3:c.264A>C:p.Arg88Arg,CDKN2A:NM_058197.4:3_prime_UTR_variant:MODIFIER:exon2/3:c.*144A>C:,C9orf53:NR_024274.1:downstream_gene_variant:MODIFIER::n.*616T>G:		rs200429615	0	0.0011	0.0011	0	5.3730	D	D,D	156540 [MTAP (confirmed) Diaphyseal medullary stenosis with malignant fibrous histiocytoma]:600160 [CDKN2A (confirmed) Melanoma,cutaneous malignant,2|Melanoma and neural system tumor syndrome|Pancreatic cancer/melanoma syndrome|Orolaryngeal cancer,multiple,];						COSM4163711, COSM4163712, COSM4163709, COSM4163710	7	327	1	[1] old entry - no details available		PUSL1 (inh=n/a pLI=0.00)
chr9	35074917	35074917	T	C	hom		QUAL=3116;DP=98;AF=1.00;MQM=60	FANCG,VCP	splice_region_variant&intron_variant,upstream_gene	FANCG:NM_004629.1:splice_region_variant&intron_variant:LOW:exon12/13:c.1636+7A>G:,VCP:NM_007126.3:upstream_gene:MODIFIER::c.-390A>G:		rs587118	0.2202	0.396	0.396	0.4993				602956 [FANCG (confirmed) Fanconi anemia,complementation group G];							375	791				PUSL1 (inh=n/a pLI=0.00)
chr9	98209594	98209594	G	A	het	pred_pathogenic_1	QUAL=1349;DP=67;AF=0.69;MQM=60	PTCH1	missense_variant	PTCH1:NM_000264.3:missense_variant:MODERATE:exon23/24:c.3944C>T:p.Pro1315Leu,PTCH1:NM_001083607.1:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:NM_001083606.1:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:NM_001083604.1:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:NM_001083605.1:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:NM_001083602.1:missense_variant:MODERATE:exon23/24:c.3746C>T:p.Pro1249Leu,PTCH1:NM_001083603.1:missense_variant:MODERATE:exon23/24:c.3941C>T:p.Pro1314Leu		rs357564	0.3968	0.38	0.38	0.3298	9.4050	T	D,D,D,D,D,D,D,D	601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];				RCV000034575.1 [benign]; RCV000078463.5 [benign]; 	CM056376 [CLASS=DP MUT=REF PHEN="Skin cancer association with" GENE=PTCH1]; 	COSM1638395, COSM1638394, COSM1638396, COSM1638397	198	688				INTS11 (inh=n/a pLI=0.00)
chr9	98232224	98232224	A	-	het		QUAL=705;DP=57;AF=0.53;MQM=60	PTCH1,LOC100507346	splice_region_variant&intron_variant,non_coding_exon_variant	PTCH1:NM_000264.3:splice_region_variant&intron_variant:LOW:exon12/23:c.1729-11delT:,PTCH1:NM_001083607.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083606.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083604.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083605.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083602.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1531-11delT:,PTCH1:NM_001083603.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1726-11delT:,LOC100507346:NR_038982.1:non_coding_exon_variant:MODIFIER:exon4/4:n.1887delA:			0	0.0014	0.0014	0.0018				601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];							0	3				INTS11 (inh=n/a pLI=0.00)
chr10	43595968	43595968	A	G	hom		QUAL=16184;DP=519;AF=1.00;MQM=59	RET	synonymous_variant	RET:NM_020975.4:synonymous_variant:LOW:exon2/20:c.135A>G:p.Ala45Ala,RET:NM_020630.4:synonymous_variant:LOW:exon2/19:c.135A>G:p.Ala45Ala		rs1800858	0.7536	0.736	0.736	0.7394				164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];				RCV000014967.1 [other]; RCV000127776.1,RCV000153833.3 [benign,benign]; 	CM020759 [CLASS=DP MUT=REF PHEN="Hirschsprung disease association with" GENE=RET]; 	COSM4144677, COSM4144678	908	595	1	[1] old entry - no details available		INTS11 (inh=n/a pLI=0.00)
chr10	43613843	43613843	G	T	hom		QUAL=37435;DP=1133;AF=1.00;MQM=60	RET	synonymous_variant	RET:NM_020975.4:synonymous_variant:LOW:exon13/20:c.2307G>T:p.Leu769Leu,RET:NM_020630.4:synonymous_variant:LOW:exon13/19:c.2307G>T:p.Leu769Leu		rs1800861	0.7125	0.742	0.742	0.7653				164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];				RCV000021844.1 [benign]; RCV000127779.1 [benign]; RCV000154625.1,RCV000153835.3 [benign,benign]; 	CM014825 [CLASS=DP MUT=REF PHEN="Hirschsprung disease association with" GENE=RET]; 		934	602				INTS11 (inh=n/a pLI=0.00)
chr10	88635779	88635779	C	A	het		QUAL=1068;DP=69;AF=0.57;MQM=51	BMPR1A	missense_variant	BMPR1A:NM_004329.2:missense_variant:MODERATE:exon3/13:c.4C>A:p.Pro2Thr		rs11528010	0.4998	0.356	0.356	0.2562	3.7680	T	T,T	601299 [BMPR1A (confirmed) Polyposis,juvenile intestinal|Polyposis syndrome,hereditary mixed,2|Juvenile polyposis syndrome,infantile form];				RCV000034703.1 [benign]; RCV000120253.1 [not provided]; RCV000131909.2 [benign]; 		COSM3752019, COSM3752020	122	562				INTS11 (inh=n/a pLI=0.00)
chr10	104264107	104264107	C	T	hom		QUAL=9683;DP=384;AF=1.00;MQM=60	SUFU,ACTR1A	splice_region_variant&intron_variant,upstream_gene	SUFU:NM_016169.3:splice_region_variant&intron_variant:LOW:exon1/11:c.182+16C>T:,SUFU:NM_001178133.1:splice_region_variant&intron_variant:LOW:exon1/10:c.182+16C>T:,ACTR1A:NM_005736.3:upstream_gene:MODIFIER::c.-109G>A:		rs2274351	0.3962	0.477	0.477	0.56				607035 [SUFU (confirmed) Medulloblastoma,desmoplastic|Meningioma,familial,susceptibility to|Basal cell nevus syndrome];							116	190				INTS11 (inh=n/a pLI=0.00)
chr10	104387019	104387019	T	C	het		QUAL=18287;DP=1165;AF=0.49;MQM=60	SUFU	splice_region_variant&intron_variant	SUFU:NM_016169.3:splice_region_variant&intron_variant:LOW:exon11/11:c.1365+19T>C:		rs12414407	0.7196	0.663	0.663	0.6521				607035 [SUFU (confirmed) Medulloblastoma,desmoplastic|Meningioma,familial,susceptibility to|Basal cell nevus syndrome];							192	188				CPTP (inh=n/a pLI=0.00)
chr10	104389932	104389932	T	G	hom		QUAL=59124;DP=1845;AF=1.00;MQM=60	SUFU	3_prime_UTR_variant	SUFU:NM_016169.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20T>G:		rs4917980	0.9974	0.999	0.999	1											477	0				CPTP (inh=n/a pLI=0.00)
chr11	64572018	64572018	T	C	hom		QUAL=8053;DP=246;AF=1.00;MQM=60	MEN1,MAP4K2	missense_variant,upstream_gene	MEN1:NM_000244.3:missense_variant:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:NM_130800.2:missense_variant:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:NM_130801.2:missense_variant:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:NM_130799.2:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala,MEN1:NM_130802.2:missense_variant:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:NM_130803.2:missense_variant:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:NM_130804.2:missense_variant:MODERATE:exon11/11:c.1636A>G:p.Thr546Ala,MAP4K2:NM_004579.3:upstream_gene:MODIFIER::c.-93A>G:		rs2959656	0.8345	0.938	0.938	0.9959	0.1310	T	T,T,T,T,T,T,T,T,T,T	613733 [MEN1 (confirmed) Multiple endocrine neoplasia 1|Carcinoid tumor of lung|Parathyroid adenoma,somatic|Lipoma,somatic|Angiofibroma,somatic|Adrenal adenoma,somatic];				RCV000034785.3 [benign]; RCV000082334.5,RCV000121334.3 [benign,benign]; 	CM085535 [CLASS=DFP MUT=REF PHEN="Impaired sensitisation to apoptosis" GENE=MEN1]; 	COSM255213	1438	20				CPTP (inh=n/a pLI=0.00)
chr11	64572557	64572557	A	G	hom		QUAL=6507;DP=200;AF=1.00;MQM=60	MEN1,MAP4K2	synonymous_variant,upstream_gene	MEN1:NM_000244.3:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:NM_130800.2:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:NM_130801.2:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:NM_130799.2:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433His,MEN1:NM_130802.2:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:NM_130803.2:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:NM_130804.2:synonymous_variant:LOW:exon10/11:c.1314T>C:p.His438His,MAP4K2:NM_004579.3:upstream_gene:MODIFIER::c.-93T>C:		rs540012	0.976	0.993	0.993	0.9997				613733 [MEN1 (confirmed) Multiple endocrine neoplasia 1|Carcinoid tumor of lung|Parathyroid adenoma,somatic|Lipoma,somatic|Angiofibroma,somatic|Adrenal adenoma,somatic];				RCV000153486.2 [benign]; 			1462	3				TAS1R3 (inh=n/a pLI=n/a)
chr11	94212930	94212930	-	A	het		QUAL=410;DP=514;AF=0.11;MQM=60	MRE11A	splice_region_variant&intron_variant	MRE11A:NM_005591.3:splice_region_variant&intron_variant:LOW:exon4/19:c.315-4_315-3insT:,MRE11A:NM_005590.3:splice_region_variant&intron_variant:LOW:exon4/18:c.315-4_315-3insT:		rs71036325	0	0	0	0				600814 [MRE11A (provisional) Ataxia-telangiectasia-like disorder];				RCV000162501.1 [likely benign]; 			0	354	1	[1] old entry - no details available		TAS1R3 (inh=n/a pLI=n/a)
chr11	108175394	108175394	T	C	het	low_DP	QUAL=195;DP=14;AF=0.57;MQM=60	ATM	splice_region_variant&intron_variant	ATM:NM_000051.3:splice_region_variant&intron_variant:LOW:exon36/62:c.5497-8T>C:		rs3092829	0.0132	0.022	0.022	0.0334				607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];				RCV000119146.1 [benign]; RCV000128919.1 [benign]; 			5	183				TAS1R3 (inh=n/a pLI=n/a)
chr11	108175462	108175462	G	A	het		QUAL=470;DP=30;AF=0.53;MQM=60	ATM	missense_variant	ATM:NM_000051.3:missense_variant:MODERATE:exon37/63:c.5557G>A:p.Asp1853Asn		rs1801516	0.0669	0.11	0.11	0.1402	6.3420	T	T,T	607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];				RCV000116427.4 [other]; RCV000131720.2 [benign]; 	CM077896 [CLASS=DP MUT=ALT PHEN="Breast cancer bilateral association with" GENE=ATM]; 	COSM41596, COSM3736031	61	596	2	[2] Christopher Schroeder 27.04.2015		DVL1 (inh=AD pLI=0.16)
chr11	108183167	108183167	A	G	hom		QUAL=14153;DP=443;AF=1.00;MQM=60	ATM	missense_variant	ATM:NM_000051.3:missense_variant:MODERATE:exon40/63:c.5948A>G:p.Asn1983Ser		rs659243	1	1	1	0	-1.0580	T	T,T	607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];				RCV000128947.1,RCV000120149.2 [benign,benign]; 			2669	0				DVL1 (inh=AD pLI=0.16)
chr11	125525195	125525195	A	G	hom		QUAL=1963;DP=59;AF=1.00;MQM=60	CHEK1	missense_variant,non_coding_exon_variant	CHEK1:NM_001114121.2:missense_variant:MODERATE:exon13/14:c.1411A>G:p.Ile471Val,CHEK1:NM_001114122.2:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val,CHEK1:NM_001244846.1:missense_variant:MODERATE:exon12/12:c.1309A>G:p.Ile437Val,CHEK1:NM_001274.5:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val,CHEK1:NR_045204.1:non_coding_exon_variant:MODIFIER:exon12/12:n.2084A>G:,CHEK1:NR_045205.1:non_coding_exon_variant:MODIFIER:exon13/13:n.1845A>G:		rs506504	0.9858	0.973	0.973	0.9637	1.1780	T	T,T,T,T,T,T,T								1088	76				DVL1 (inh=AD pLI=0.16)
chr13	32911888	32911888	A	G	het		QUAL=1006;DP=71;AF=0.48;MQM=60	BRCA2	synonymous_variant	BRCA2:NM_000059.3:synonymous_variant:LOW:exon11/27:c.3396A>G:p.Lys1132Lys		rs1801406	0.2668	0.293	0.293	0.3074				600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];				RCV000113169.1,RCV000113170.4 [benign,benign]; RCV000114982.2 [benign]; RCV000130987.2 [benign]; RCV000152873.3 [benign]; 			151	773	1	[1] Ulrike Faust 13.06.2015		DVL1 (inh=AD pLI=0.16)
chr13	32913055	32913055	A	G	hom		QUAL=31796;DP=973;AF=1.00;MQM=60	BRCA2	synonymous_variant	BRCA2:NM_000059.3:synonymous_variant:LOW:exon11/27:c.4563A>G:p.Leu1521Leu		rs206075	0.974	0.993	0.993	0.9994				600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];				RCV000113321.1,RCV000160224.1 [benign,benign]; RCV000164515.1,RCV000119245.2 [likely benign,benign]; RCV000123972.2 [benign]; RCV000132170.2 [benign]; RCV000152875.4 [benign]; 			1726	7	1	[1] Ulrike Faust 13.06.2015		MXRA8 (inh=n/a pLI=0.00)
chr13	32915005	32915005	G	C	hom		QUAL=857;DP=26;AF=1.00;MQM=60	BRCA2	synonymous_variant	BRCA2:NM_000059.3:synonymous_variant:LOW:exon11/27:c.6513G>C:p.Val2171Val		rs206076	0.9736	0.993	0.993	0.9994				600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];				RCV000113602.1,RCV000119246.2 [not provided,benign]; RCV000123985.2 [benign]; RCV000152878.4 [benign]; RCV000162377.1,RCV000160234.1 [benign,benign]; RCV000163332.1 [likely benign]; RCV000168590.1 [uncertain significance]; RCV000173959.1 [uncertain significance]; 		COSM4147690, COSM4147689	1728	9	1	[1] old entry - no details available		MXRA8 (inh=n/a pLI=0.00)
chr13	32929232	32929232	A	G	het		QUAL=541;DP=35;AF=0.54;MQM=60	BRCA2	synonymous_variant	BRCA2:NM_000059.3:synonymous_variant:LOW:exon14/27:c.7242A>G:p.Ser2414Ser		rs1799955	0.2326	0.224	0.224	0.2133				600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];				RCV000113739.4 [benign]; RCV000123992.2 [benign]; RCV000130994.2 [benign]; RCV000152882.3 [benign]; 			75	631	1	[1] Ulrike Faust 13.06.2015		MXRA8 (inh=n/a pLI=0.00)
chr13	32929387	32929387	T	C	hom	anno_pathogenic_hgmd	QUAL=19184;DP=582;AF=1.00;MQM=60	BRCA2	missense_variant	BRCA2:NM_000059.3:missense_variant:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala		rs169547	0.9758	0.994	0.994	0.9994	2.3530	T	T,T	600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];				RCV000045197.3 [benign]; RCV000113751.2 [benign]; RCV000168597.1,RCV000120357.4 [benign,benign]; 	CM960194 [CLASS=DM? MUT=REF PHEN="Breast cancer" GENE=BRCA2]; 		1738	7	2	[2] old entry - no details available		MXRA8 (inh=n/a pLI=0.00)
chr14	45606387	45606387	A	G	het	pred_pathogenic_3	QUAL=743;DP=52;AF=0.48;MQM=60	FANCM,FKBP3	missense_variant,upstream_gene	FANCM:NM_020937.2:missense_variant:MODERATE:exon2/23:c.624A>G:p.Ile208Met,FKBP3:NM_002013.3:upstream_gene:MODIFIER::c.-74T>C:		rs45547534	0.0054	0.011	0.011	0.0151	0.1250	T	D,D,D							COSM3753963	0	20				AURKAIP1 (inh=n/a pLI=0.00)
chr14	104165753	104165753	G	A	het		QUAL=15606;DP=948;AF=0.51;MQM=60	XRCC3,KLC1	missense_variant,intron_variant	XRCC3:NM_001100118.1:missense_variant:MODERATE:exon7/9:c.722C>T:p.Thr241Met,XRCC3:NM_001100119.1:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met,XRCC3:NM_005432.3:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met,KLC1:NM_001130107.1:intron_variant:MODIFIER:exon14/15:c.1782-1239G>A:,KLC1:NM_182923.3:intron_variant:MODIFIER:exon13/14:c.1651-1239G>A:		rs861539	0.2169	0.292	0.292	0.3782	0.6420	T	T,T,T,T,T,T	600675 [XRCC3 (provisional) Melanoma,cutaneous malignant,6|Breast cancer,susceptibility to];				RCV000009500.1 [other]; 	CM003625 [CLASS=DFP MUT=ALT PHEN="Melanoma association with" GENE=XRCC3]; 	COSM1128325	205	673	1	[1] old entry - no details available		CCNL2 (inh=n/a pLI=0.10)
chr15	43701947	43701947	A	-	het		QUAL=708;DP=58;AF=0.43;MQM=60	TP53BP1,TUBGCP4,RNU6-28P	splice_region_variant&intron_variant,downstream_gene_variant,intron_variant	TP53BP1:NM_001141980.1:splice_region_variant&intron_variant:LOW:exon24/27:c.5306-8delT:,TP53BP1:NM_001141979.1:splice_region_variant&intron_variant:LOW:exon24/27:c.5300-8delT:,TP53BP1:NM_005657.2:splice_region_variant&intron_variant:LOW:exon24/27:c.5291-8delT:,TUBGCP4:NM_001286414.1:downstream_gene_variant:MODIFIER::c.*2300delA:,TUBGCP4:NM_014444.3:downstream_gene_variant:MODIFIER::c.*2297delA:,RNU6-28P:NR_046489.1.2:intron_variant:MODIFIER:exon4/4:n.34+18528delA:		rs397711844	0.2502	0	0	0										COSM1608394	86	522	1	[1] old entry - no details available		CCNL2 (inh=n/a pLI=0.10)
chr15	43707808	43707808	A	T	het		QUAL=1980;DP=130;AF=0.47;MQM=60	TP53BP1,RNU6-28P	synonymous_variant,intron_variant	TP53BP1:NM_001141980.1:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691Ser,TP53BP1:NM_001141979.1:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691Ser,TP53BP1:NM_005657.2:synonymous_variant:LOW:exon23/28:c.5058T>A:p.Ser1686Ser,RNU6-28P:NR_046489.1.2:intron_variant:MODIFIER:exon4/4:n.34+24389A>T:		rs2230451	0.1286	0.163	0.163	0.19										COSM3754329	73	430				CCNL2 (inh=n/a pLI=0.10)
chr15	43724646	43724646	T	G	hom		QUAL=19907;DP=624;AF=1.00;MQM=60	TP53BP1,RNU6-28P	missense_variant,intron_variant	TP53BP1:NM_001141980.1:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln,TP53BP1:NM_001141979.1:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln,TP53BP1:NM_005657.2:missense_variant:MODERATE:exon17/28:c.3406A>C:p.Lys1136Gln,RNU6-28P:NR_046489.1.2:intron_variant:MODIFIER:exon4/4:n.34+41227T>G:		rs2602141	0.5264	0.375	0.375	0.3036	3.2610	T	T,T,T,T						CM067476 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1]; 	COSM3754330	168	557				CCNL2 (inh=n/a pLI=0.10)
chr15	43748304	43748304	A	G	hom		QUAL=30130;DP=949;AF=1.00;MQM=60	TP53BP1,RNU6-28P	synonymous_variant,intron_variant	TP53BP1:NM_001141980.1:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834Asp,TP53BP1:NM_001141979.1:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834Asp,TP53BP1:NM_005657.2:synonymous_variant:LOW:exon12/28:c.2487T>C:p.Asp829Asp,RNU6-28P:NR_046489.1.2:intron_variant:MODIFIER:exon4/4:n.34+64885A>G:		rs690367	0.5262	0.374	0.374	0.3032										COSM3754331	169	554				ANKRD65 (inh=n/a pLI=n/a)
chr15	43762196	43762196	C	T	het	pred_pathogenic_1	QUAL=3865;DP=203;AF=0.59;MQM=60	TP53BP1,RNU6-28P	missense_variant,intron_variant	TP53BP1:NM_001141980.1:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser,TP53BP1:NM_001141979.1:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser,TP53BP1:NM_005657.2:missense_variant:MODERATE:exon11/28:c.1234G>A:p.Gly412Ser,RNU6-28P:NR_046489.1.2:intron_variant:MODIFIER:exon4/4:n.34+78777C>T:		rs689647	0.3824	0.206	0.206	0.113	1.1390	T	D,D,D,D,T						CM107902 [CLASS=DP MUT=ALT PHEN="Basal cell carcinoma reduced risk association with" GENE=TP53BP1]; 	COSM3754332	26	263				ANKRD65 (inh=n/a pLI=n/a)
chr15	43767774	43767774	G	C	hom		QUAL=3608;DP=116;AF=1.00;MQM=60	TP53BP1,RNU6-28P	missense_variant,intron_variant	TP53BP1:NM_001141980.1:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu,TP53BP1:NM_001141979.1:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu,TP53BP1:NM_005657.2:missense_variant:MODERATE:exon9/28:c.1059C>G:p.Asp353Glu,RNU6-28P:NR_046489.1.2:intron_variant:MODIFIER:exon4/4:n.34+84355G>C:		rs560191	0.5258	0.374	0.374	0.3029	0.2260	T	T,T,T,T,T						CM067475 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1]; 	COSM3744615	169	554				ANKRD65 (inh=n/a pLI=n/a)
chr16	3639139	3639139	A	G	het		QUAL=1640;DP=100;AF=0.53;MQM=60	SLX4	synonymous_variant	SLX4:NM_032444.2:synonymous_variant:LOW:exon12/15:c.4500T>C:p.Asn1500Asn		rs3810812	0.7396	0.611	0.611	0.5077				613278 [SLX4 (provisional) Fanconi anemia,complementation group P];							393	685				ANKRD65 (inh=n/a pLI=n/a), RP4-758J18.7 (inh=n/a pLI=n/a)
chr16	3639230	3639230	G	A	het	anno_pathogenic_hgmd	QUAL=1724;DP=109;AF=0.49;MQM=60	SLX4	missense_variant	SLX4:NM_032444.2:missense_variant:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu		rs72778139	0.0002	0.0001	0.0001	0.0002	0.3390	T	T	613278 [SLX4 (provisional) Fanconi anemia,complementation group P];					CM136925 [CLASS=DM MUT=ALT PHEN="Breast and/or ovarian cancer" GENE=SLX4]; 		0	1				TMEM88B (inh=n/a pLI=n/a)
chr16	68771372	68771372	C	T	hom		QUAL=3991;DP=125;AF=1.00;MQM=60	CDH1	splice_region_variant&intron_variant	CDH1:NM_004360.3:splice_region_variant&intron_variant:LOW:exon1/15:c.48+6C>T:		rs3743674	0.7634	0.731	0.731	0.9074				192090 [CDH1 (confirmed) Endometrial carcinoma,somatic|Ovarian carcinoma,somatic|Breast cancer,lobular|Gastric cancer,familial diffuse,with or without cleft lip and/or palate|Prostate cancer,susceptibility to];				RCV000132163.2 [benign]; RCV000173339.1 [benign]; 			1155	287				TMEM88B (inh=n/a pLI=n/a)
chr16	68857441	68857441	T	C	het		QUAL=18115;DP=1126;AF=0.52;MQM=60	CDH1	synonymous_variant	CDH1:NM_004360.3:synonymous_variant:LOW:exon13/16:c.2076T>C:p.Ala692Ala		rs1801552	0.7187	0.655	0.655	0.6322				192090 [CDH1 (confirmed) Endometrial carcinoma,somatic|Ovarian carcinoma,somatic|Breast cancer,lobular|Gastric cancer,familial diffuse,with or without cleft lip and/or palate|Prostate cancer,susceptibility to];				RCV000132164.2 [benign]; 		COSM3755010	610	762				TMEM88B (inh=n/a pLI=n/a)
chr16	89836323	89836323	C	T	het	anno_pathogenic_hgmd	QUAL=1084;DP=92;AF=0.40;MQM=60	FANCA	missense_variant	FANCA:NM_000135.2:missense_variant:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp,FANCA:NM_001286167.1:missense_variant:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp		rs7195066	0.6667	0.467	0.467	0.3142	0.3050	T	T	607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				RCV000120927.1 [not provided]; 	CM137288 [CLASS=DM? MUT=ALT PHEN="Fanconi anaemia A" GENE=FANCA]; 	COSM435949	183	675	2	[2] old entry - no details available		TMEM88B (inh=n/a pLI=n/a)
chr16	89838078	89838078	A	G	het		QUAL=15879;DP=1034;AF=0.48;MQM=60	FANCA	splice_region_variant&intron_variant	FANCA:NM_000135.2:splice_region_variant&intron_variant:LOW:exon23/42:c.2151+8T>C:,FANCA:NM_001286167.1:splice_region_variant&intron_variant:LOW:exon23/42:c.2151+8T>C:		rs1800340	0.5599	0.431	0.431	0.3077				607139 [FANCA (confirmed) Fanconi anemia,complementation group A];							161	661				VWA1 (inh=n/a pLI=0.03)
chr16	89849480	89849480	C	T	hom		QUAL=6699;DP=199;AF=1.00;MQM=60	FANCA	missense_variant	FANCA:NM_000135.2:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser,FANCA:NM_001286167.1:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser		rs2239359	0.624	0.499	0.499	0.381	-0.0380	T	T	607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				RCV000120917.1 [not provided]; 	CM137880 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA]; 		271	763				ATAD3B (inh=n/a pLI=0.00)
chr16	89866043	89866043	T	C	het		QUAL=11520;DP=724;AF=0.50;MQM=60	FANCA	missense_variant	FANCA:NM_000135.2:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala,FANCA:NM_001286167.1:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala,FANCA:NM_001018112.1:missense_variant:MODERATE:exon9/11:c.796A>G:p.Thr266Ala		rs7190823	0.6905	0.517	0.517	0.3937	0.4020	T	T,T,T,T	607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				RCV000120967.1 [not provided]; 	CM137879 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA]; 		256	731				ATAD3B (inh=n/a pLI=0.00)
chr17	7579472	7579472	G	C	het		QUAL=9225;DP=555;AF=0.54;MQM=60	TP53	missense_variant,upstream_gene	TP53:NM_000546.5:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg,TP53:NM_001126112.2:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg,TP53:NM_001126113.2:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg,TP53:NM_001126114.2:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg,TP53:NM_001126118.1:missense_variant:MODERATE:exon3/10:c.98C>G:p.Pro33Arg,TP53:NM_001276695.1:missense_variant:MODERATE:exon4/12:c.98C>G:p.Pro33Arg,TP53:NM_001276696.1:missense_variant:MODERATE:exon4/12:c.98C>G:p.Pro33Arg,TP53:NM_001276760.1:missense_variant:MODERATE:exon4/11:c.98C>G:p.Pro33Arg,TP53:NM_001276761.1:missense_variant:MODERATE:exon4/11:c.98C>G:p.Pro33Arg,TP53:NM_001126115.1:upstream_gene:MODIFIER::c.-279C>G:,TP53:NM_001126116.1:upstream_gene:MODIFIER::c.-279C>G:,TP53:NM_001126117.1:upstream_gene:MODIFIER::c.-279C>G:,TP53:NM_001276697.1:upstream_gene:MODIFIER::c.-360C>G:,TP53:NM_001276698.1:upstream_gene:MODIFIER::c.-360C>G:,TP53:NM_001276699.1:upstream_gene:MODIFIER::c.-360C>G:		rs1042522	0.5429	0.659	0.659	0.7452	1.0150	T	T,T,T,T,T,T,T,T,T	191170 [TP53 (confirmed) Colorectal cancer|Li-Fraumeni syndrome|Hepatocellular carcinoma|Osteosarcoma|Choroid plexus papilloma|Nasopharyngeal carcinoma|Pancreatic cancer|Adrenal cortical carcinoma|Breast cancer|Basal cell carcinoma 7|Glioma susceptibility 1];				RCV000152112.1,RCV000013144.1 [benign,benign]; RCV000034639.1 [benign]; RCV000079202.5 [benign]; RCV000132165.2 [benign]; RCV000144668.1,RCV000164487.1 [uncertain significance,uncertain significance]; 	CM961374 [CLASS=DFP MUT=REF PHEN="Lung cancer association with" GENE=TP53]; 	COSM250061, COSM3766192, COSM3766191, COSM3766190, COSM3766193	871	622	1	[1] old entry - no details available		ATAD3B (inh=n/a pLI=0.00)
chr17	29553485	29553485	G	A	hom		QUAL=2516;DP=83;AF=1.00;MQM=60	NF1	synonymous_variant,downstream_gene_variant	NF1:NM_001042492.2:synonymous_variant:LOW:exon18/58:c.2034G>A:p.Pro678Pro,NF1:NM_000267.3:synonymous_variant:LOW:exon18/57:c.2034G>A:p.Pro678Pro,NF1:NM_001128147.2:downstream_gene_variant:MODIFIER::c.*2165G>A:		rs2285892	0.4968	0.382	0.382	0.2891				613113 [NF1 (confirmed) Neurofibromatosis,type 1|Leukemia,juvenile myelomonocytic|Neurofibromatosis,familial spinal|Neurofibromatosis-Noonan syndrome|Watson syndrome];				RCV000162648.1 [benign]; 			138	634				ATAD3A (inh=AR+AD pLI=0.04)
chr17	33433487	33433487	C	T	hom		QUAL=2516;DP=84;AF=1.00;MQM=60	RAD51D,RAD51L3-RFFL	missense_variant,non_coding_exon_variant	RAD51D:NM_001142571.1:missense_variant:MODERATE:exon6/10:c.554G>A:p.Arg185Gln,RAD51D:NM_002878.3:missense_variant:MODERATE:exon6/10:c.494G>A:p.Arg165Gln,RAD51D:NM_133629.2:missense_variant:MODERATE:exon3/7:c.158G>A:p.Arg53Gln,RAD51L3-RFFL:NR_037714.1:non_coding_exon_variant:MODIFIER:exon2/7:n.246G>A:,RAD51D:NR_037711.1:non_coding_exon_variant:MODIFIER:exon5/9:n.631G>A:,RAD51D:NR_037712.1:non_coding_exon_variant:MODIFIER:exon4/8:n.496G>A:		rs4796033	0.095	0.148	0.148	0.1427	1.3260	T	T,T,T,T,T,T,T	602954 [RAD51D (provisional) Breast-ovarian cancer,familial,susceptibility to,4];				RCV000131069.2 [benign]; 			34	372	1	[1] Christopher Schroeder 27.04.2015		ATAD3A (inh=AR+AD pLI=0.04)
chr17	33445549	33445549	G	A	het		QUAL=1831;DP=114;AF=0.51;MQM=60	RAD51D,FNDC8,RAD51L3-RFFL	synonymous_variant,upstream_gene,intron_variant	RAD51D:NM_002878.3:synonymous_variant:LOW:exon3/10:c.234C>T:p.Ser78Ser,FNDC8:NM_017559.2:upstream_gene:MODIFIER::c.-83G>A:,RAD51L3-RFFL:NR_037714.1:intron_variant:MODIFIER:exon1/6:n.232+2761C>T:,RAD51D:NM_001142571.1:intron_variant:MODIFIER:exon2/9:c.144+581C>T:,RAD51D:NM_133629.2:intron_variant:MODIFIER:exon2/6:c.144+581C>T:,RAD51D:NR_037711.1:intron_variant:MODIFIER:exon2/8:n.400+581C>T:,RAD51D:NR_037712.1:intron_variant:MODIFIER:exon2/7:n.400+581C>T:		rs9901455	0.1875	0.118	0.118	0.082				602954 [RAD51D (provisional) Breast-ovarian cancer,familial,susceptibility to,4];				RCV000162563.1 [benign]; 			17	274				ATAD3A (inh=AR+AD pLI=0.04)
chr17	41223094	41223094	T	C	het	pred_pathogenic_1	QUAL=5538;DP=414;AF=0.46;MQM=60	BRCA1	missense_variant,non_coding_exon_variant	BRCA1:NM_007300.3:missense_variant:MODERATE:exon16/24:c.4900A>G:p.Ser1634Gly,BRCA1:NM_007298.3:missense_variant:MODERATE:exon14/22:c.1525A>G:p.Ser509Gly,BRCA1:NM_007297.3:missense_variant:MODERATE:exon14/22:c.4696A>G:p.Ser1566Gly,BRCA1:NM_007299.3:missense_variant:MODERATE:exon15/22:c.1525A>G:p.Ser509Gly,BRCA1:NM_007294.3:missense_variant:MODERATE:exon15/23:c.4837A>G:p.Ser1613Gly,BRCA1:NR_027676.1:non_coding_exon_variant:MODIFIER:exon15/23:n.4973A>G:		rs1799966	0.3558	0.349	0.349	0.3266	-0.1120	T	D,T,D,T,D,T,T,T,D,.,D,D,D	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];				RCV000031194.5 [other]; RCV000048673.4 [likely benign]; RCV000130704.2 [likely benign]; RCV000167795.1,RCV000034753.3 [likely benign,benign]; RCV000048672.5 [benign]; RCV000112410.4 [benign]; RCV000119096.1 [benign]; RCV000120260.4 [benign]; RCV000128996.2 [benign]; 	CM1210129 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1]; 	COSM3755560, COSM3755559	186	715	2	[2] old entry - no details available		MIB2 (inh=n/a pLI=0.00)
chr17	41234470	41234470	A	G	het		QUAL=408;DP=32;AF=0.47;MQM=60	BRCA1	synonymous_variant,non_coding_exon_variant	BRCA1:NM_007300.3:synonymous_variant:LOW:exon12/24:c.4308T>C:p.Ser1436Ser,BRCA1:NM_007298.3:synonymous_variant:LOW:exon11/22:c.999T>C:p.Ser333Ser,BRCA1:NM_007297.3:synonymous_variant:LOW:exon11/22:c.4167T>C:p.Ser1389Ser,BRCA1:NM_007299.3:synonymous_variant:LOW:exon12/22:c.999T>C:p.Ser333Ser,BRCA1:NM_007294.3:synonymous_variant:LOW:exon12/23:c.4308T>C:p.Ser1436Ser,BRCA1:NR_027676.1:non_coding_exon_variant:MODIFIER:exon12/23:n.4444T>C:		rs1060915	0.3363	0.343	0.343	0.326	-0.1190	T		113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];				RCV000112313.4 [benign]; RCV000114988.2 [benign]; RCV000128938.2 [benign]; RCV000152866.3 [benign]; 			184	712	1	[1] Ulrike Faust 13.06.2015		MIB2 (inh=n/a pLI=0.00)
chr17	41244000	41244000	T	C	het		QUAL=5726;DP=347;AF=0.49;MQM=60	BRCA1	missense_variant,intron_variant,non_coding_exon_variant	BRCA1:NM_007300.3:missense_variant:MODERATE:exon10/24:c.3548A>G:p.Lys1183Arg,BRCA1:NM_007297.3:missense_variant:MODERATE:exon9/22:c.3407A>G:p.Lys1136Arg,BRCA1:NM_007294.3:missense_variant:MODERATE:exon10/23:c.3548A>G:p.Lys1183Arg,BRCA1:NM_007298.3:intron_variant:MODIFIER:exon9/21:c.788-951A>G:,BRCA1:NM_007299.3:intron_variant:MODIFIER:exon10/21:c.788-951A>G:,BRCA1:NR_027676.1:non_coding_exon_variant:MODIFIER:exon10/23:n.3684A>G:		rs16942	0.3526	0.348	0.348	0.3244	-0.3650	T	T,T,T,T,T,T,T	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];				RCV000034742.3 [benign]; RCV000048229.3 [benign]; RCV000112115.4 [benign]; RCV000120278.4 [benign]; RCV000128991.2 [benign]; RCV000157734.1 [benign]; 	CM058359 [CLASS=DP MUT=ALT PHEN="Breast cancer protection against association with" GENE=BRCA1]; 	COSM3755561, COSM148277	185	711	1	[1] old entry - no details available		MIB2 (inh=n/a pLI=0.00)
chr17	41244435	41244435	T	C	het	pred_pathogenic_1	QUAL=13607;DP=958;AF=0.48;MQM=60	BRCA1	missense_variant,intron_variant,non_coding_exon_variant	BRCA1:NM_007300.3:missense_variant:MODERATE:exon10/24:c.3113A>G:p.Glu1038Gly,BRCA1:NM_007297.3:missense_variant:MODERATE:exon9/22:c.2972A>G:p.Glu991Gly,BRCA1:NM_007294.3:missense_variant:MODERATE:exon10/23:c.3113A>G:p.Glu1038Gly,BRCA1:NM_007298.3:intron_variant:MODIFIER:exon9/21:c.788-1386A>G:,BRCA1:NM_007299.3:intron_variant:MODIFIER:exon10/21:c.788-1386A>G:,BRCA1:NR_027676.1:non_coding_exon_variant:MODIFIER:exon10/23:n.3249A>G:		rs16941	0.3357	0.343	0.343	0.3255	-0.4800	T	D,D,D,D,D,D,D	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];				RCV000034738.3 [benign]; RCV000112006.4 [benign]; RCV000114987.2 [benign]; RCV000120276.4 [benign]; RCV000128978.2 [benign]; 	CM032861 [CLASS=DP MUT=ALT PHEN="Endometriosis association with" GENE=BRCA1]; 	COSM3755563, COSM3755562	184	711	1	[1] old entry - no details available		MIB2 (inh=n/a pLI=0.00)
chr17	41244936	41244936	G	A	het		QUAL=2483;DP=128;AF=0.59;MQM=60	BRCA1	missense_variant,intron_variant,non_coding_exon_variant	BRCA1:NM_007300.3:missense_variant:MODERATE:exon10/24:c.2612C>T:p.Pro871Leu,BRCA1:NM_007297.3:missense_variant:MODERATE:exon9/22:c.2471C>T:p.Pro824Leu,BRCA1:NM_007294.3:missense_variant:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu,BRCA1:NM_007298.3:intron_variant:MODIFIER:exon9/21:c.787+1825C>T:,BRCA1:NM_007299.3:intron_variant:MODIFIER:exon10/21:c.787+1825C>T:,BRCA1:NR_027676.1:non_coding_exon_variant:MODIFIER:exon10/23:n.2748C>T:		rs799917	0.5439	0.41	0.41	0.3359	4.2460	T	T,T,T,T,T,T,T	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];				RCV000034735.3 [benign]; RCV000111903.4 [benign]; RCV000114986.2 [benign]; RCV000120285.4 [benign]; RCV000132149.2,RCV000077111.2,RCV000047899.2 [benign,likely benign,not provided]; RCV000111902.1 [uncertain significance]; 	CM096315 [CLASS=DFP MUT=ALT PHEN="Cervical cancer decreased risk association with" GENE=BRCA1]; 	COSM148278, COSM3755564	199	728	1	[1] Christopher Schroeder 27.04.2015		CDK11B (inh=AD pLI=0.73)
chr17	41245237	41245237	A	G	het		QUAL=1908;DP=126;AF=0.46;MQM=60	BRCA1	synonymous_variant,intron_variant,non_coding_exon_variant	BRCA1:NM_007300.3:synonymous_variant:LOW:exon10/24:c.2311T>C:p.Leu771Leu,BRCA1:NM_007297.3:synonymous_variant:LOW:exon9/22:c.2170T>C:p.Leu724Leu,BRCA1:NM_007294.3:synonymous_variant:LOW:exon10/23:c.2311T>C:p.Leu771Leu,BRCA1:NM_007298.3:intron_variant:MODIFIER:exon9/21:c.787+1524T>C:,BRCA1:NM_007299.3:intron_variant:MODIFIER:exon10/21:c.787+1524T>C:,BRCA1:NR_027676.1:non_coding_exon_variant:MODIFIER:exon10/23:n.2447T>C:		rs16940	0.3353	0.342	0.342	0.3237				113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];				RCV000111822.4 [benign]; RCV000114985.2 [benign]; RCV000128982.2 [benign]; RCV000152867.3 [benign]; 		COSM3755566, COSM3755565	181	709	1	[1] Ulrike Faust 13.06.2015		CDK11B (inh=AD pLI=0.73)
chr17	41245466	41245466	G	A	het		QUAL=627;DP=60;AF=0.43;MQM=60	BRCA1	synonymous_variant,intron_variant,non_coding_exon_variant	BRCA1:NM_007300.3:synonymous_variant:LOW:exon10/24:c.2082C>T:p.Ser694Ser,BRCA1:NM_007297.3:synonymous_variant:LOW:exon9/22:c.1941C>T:p.Ser647Ser,BRCA1:NM_007294.3:synonymous_variant:LOW:exon10/23:c.2082C>T:p.Ser694Ser,BRCA1:NM_007298.3:intron_variant:MODIFIER:exon9/21:c.787+1295C>T:,BRCA1:NM_007299.3:intron_variant:MODIFIER:exon10/21:c.787+1295C>T:,BRCA1:NR_027676.1:non_coding_exon_variant:MODIFIER:exon10/23:n.2218C>T:		rs1799949	0.3365	0.348	0.348	0.3244				113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];				RCV000111763.4 [benign]; RCV000114984.2 [benign]; RCV000128966.2 [benign]; RCV000152868.3 [benign]; 		COSM148280, COSM3755567	185	710	1	[1] Ulrike Faust 13.06.2015		CDK11B (inh=AD pLI=0.73)
chr17	59760996	59760996	A	G	hom		QUAL=7602;DP=305;AF=1.00;MQM=60	BRIP1	synonymous_variant	BRIP1:NM_032043.2:synonymous_variant:LOW:exon20/20:c.3411T>C:p.Tyr1137Tyr		rs4986763	0.6208	0.594	0.594	0.5869				605882 [BRIP1 (confirmed) Breast cancer,early-onset|Fanconi anemia,complementation group J];				RCV000162378.1 [benign]; 			564	780				CDK11B (inh=AD pLI=0.73)
chr17	59763347	59763347	A	G	hom	low_DP	QUAL=369;DP=12;AF=1.00;MQM=60	BRIP1	missense_variant	BRIP1:NM_032043.2:missense_variant:MODERATE:exon19/20:c.2755T>C:p.Ser919Pro		rs4986764	0.6278	0.597	0.597	0.589	0.1360	T	T	605882 [BRIP1 (confirmed) Breast cancer,early-onset|Fanconi anemia,complementation group J];				RCV000120400.1 [not provided]; RCV000132148.2 [benign]; 	CM046104 [CLASS=DP MUT=REF PHEN="Breast cancer association with" GENE=BRIP1]; 		568	779				CDK11B (inh=AD pLI=0.73)
chr17	59763465	59763465	T	C	hom		QUAL=3657;DP=113;AF=1.00;MQM=60	BRIP1	synonymous_variant	BRIP1:NM_032043.2:synonymous_variant:LOW:exon19/20:c.2637A>G:p.Glu879Glu		rs4986765	0.8151	0.719	0.719	0.6555				605882 [BRIP1 (confirmed) Breast cancer,early-onset|Fanconi anemia,complementation group J];				RCV000162379.1 [pathogenic]; 		COSM437064, COSM1479821	754	705				CDK11B (inh=AD pLI=0.73)
chr19	17389648	17389648	C	T	het		QUAL=1535;DP=106;AF=0.47;MQM=60	BABAM1,ANKLE1	splice_region_variant&intron_variant,upstream_gene	BABAM1:NM_001033549.2:splice_region_variant&intron_variant:LOW:exon8/8:c.787-6C>T:,BABAM1:NM_001288756.1:splice_region_variant&intron_variant:LOW:exon8/8:c.787-6C>T:,BABAM1:NM_001288757.1:splice_region_variant&intron_variant:LOW:exon5/5:c.562-6C>T:,BABAM1:NM_014173.3:splice_region_variant&intron_variant:LOW:exon8/8:c.787-6C>T:,ANKLE1:NM_152363.5:upstream_gene:MODIFIER::c.-115C>T:,ANKLE1:NM_001278443.1:upstream_gene:MODIFIER::c.-115C>T:,ANKLE1:NM_001278444.1:upstream_gene:MODIFIER::c.-115C>T:,ANKLE1:NM_001278445.1:upstream_gene:MODIFIER::c.-206C>T:,ANKLE1:NR_103530.1:upstream_gene:MODIFIER::n.-1C>T:		rs10406920	0.1118	0.148	0.148	0.1799											33	301				CDK11B (inh=AD pLI=0.73)
chr19	17389704	17389704	G	A	het		QUAL=7841;DP=526;AF=0.47;MQM=60	BABAM1,ANKLE1	synonymous_variant,upstream_gene	BABAM1:NM_001033549.2:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279Lys,BABAM1:NM_001288756.1:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279Lys,BABAM1:NM_001288757.1:synonymous_variant:LOW:exon6/6:c.612G>A:p.Lys204Lys,BABAM1:NM_014173.3:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279Lys,ANKLE1:NM_152363.5:upstream_gene:MODIFIER::c.-115G>A:,ANKLE1:NM_001278443.1:upstream_gene:MODIFIER::c.-115G>A:,ANKLE1:NM_001278444.1:upstream_gene:MODIFIER::c.-115G>A:,ANKLE1:NM_001278445.1:upstream_gene:MODIFIER::c.-206G>A:,ANKLE1:NR_103530.1:upstream_gene:MODIFIER::n.-1G>A:		rs8170	0.1124	0.152	0.152	0.1811									CM1010189 [CLASS=DP MUT=ALT PHEN="Ovarian cancer susceptibility to" GENE=BABAM1]; 	COSM438891, COSM438892	33	302				CDK11B (inh=AD pLI=0.73)